Protocol for optogenetic control of cAMP in human telencephalic organoids using an easy-to-build Arduino-driven LED system Authors: Issei S. Shimada, Yoichi Kato Published: 2026 ABSTRACT SummaryTemporal regulation of cyclic adenosine monophosphate (cAMP) using photoactivated adenylyl cyclase (bPAC) is critical in research; however, commercial optogenetic systems are costly. Here, we present a protocol for optogenetic control of cAMP in human telencephalic organoids using an easy-to-build Arduino-driven light-emitting diode (LED) stimulation system. We describe steps for assembling the system, writing code for LED regulation, and preparing induced pluripotent stem (iPS) cells for optogenetic experiments. We then detail procedures for optogenetic activation of cAMP to control cell-fate decisions.For complete information on the generation and use of this protocol, please refer to Shimada et al.1 Before you begin Cyclic adenosine monophosphate (cAMP)1 is a second messenger that participates in various signaling pathways. Following activation of G protein-coupled receptors (GPCRs), G-protein α subunit (Gαs) stimulates adenylyl cyclase to produce cAMP. One critical function of cAMP is the negative regulation of Sonic hedgehog (SHH) signaling by promoting GLI family zinc finger 3 (GLI3) processing into its repressor form.2 SHH is a critical morphogen for brain development.3 During neural tube development, SHH determines the dorsal/ventral axis of neural stem/progenitor cells (NSCs). In the developing forebrain, including the telencephalon, SHH promotes ventral identities.4 In primary cilia, which are antenna-like organelles that protrude from the cell surface, G protein-coupled receptor 161 (GPR161)-generated cAMP activates protein kinase A (PKA). PKA then phosphorylates GLI3, which promotes its ubiquitination by β-transducin repeat-containing protein (β-TrCP) and its processing into the N-terminal GLI3 repressor.5 The GLI3 repressor suppresses transcription of SHH target genes. Therefore, cAMP is important for suppressing SHH signaling. To increase cAMP levels in cells, photoactivated adenylyl cyclase (bPAC) is commonly used as an optogenetic tool.6 Due to the high basal activity of bPAC, a low-basal-activity mutant, bPACF198Y, was developed.7 Here, we generate bPACF198Y-expressing induced pluripotent stem (iPS) cell-derived telencephalic organoids to examine the function of cAMP during brain development. To target bPACF198Y to primary cilia, ADP-ribosylation factor-like protein 13B (Arl13b) is fused to the N terminus of bPACF198Y. For application in iPS cells, we recommend generating stable bPACF198Y-expressing iPS cells by targeted insertion into the adeno-associated virus integration site 1 (AAVS1) locus on chromosome 19.8 This protocol also includes a commonly used method for generating telencephalic organoids. Optogenetics enables regulation of cellular processes by light stimulation. In general, optogenetic experiments require expensive commercial equipment, which may limit their use in laboratories with limited resources. The optogenetic system described here consists of four components: cells expressing a light-responsive optogenetic regulator, a 470-nm light-emitting diode (LED), an Arduino-based controller, and code that regulates the temporal pattern of illumination. Innovation The high cost of commercially available optogenetic stimulation systems can interfere with research progress. This protocol reduces this financial barrier by providing an inexpensive and beginner-friendly Arduino-controlled LED system. Because no soldering is required, the device is easy to build. In addition, we provide simple Arduino code that users can copy and upload to their own Arduino. Moreover, the protocol can be used for bPAC-mediated manipulation of cAMP signaling in iPS cell-derived telencephalic organoids and can be used in various organoid research fields. This workflow makes optogenetic cAMP manipulation more accessible for organoid studies. Institutional permissions Experiments using human iPS cells may require approval from the relevant institutional review board (IRB) or ethics committee, in accordance with local regulations and institutional policies. In addition, experiments involving plasmids, clustered regularly interspaced palindromic repeats (CRISPR)/Cas9, recombinant DNA, or genetically modified cells may require prior approval from the institutional biosafety committee (IBC) or other committee responsible for oversight of recombinant DNA and genetic manipulation. Users should confirm and obtain all required institutional permissions before starting the protocol. Software installation Timing: 30 min Timing: 30 min This section describes how to install Arduino IDE.1.Install the latest version of Arduino integrated development environment (IDE): This protocol was tested using Arduino IDE 2.3.10. Newer compatible versions may also be used.2.Arduino IDE can be installed on Windows 10 or later (64-bit), macOS 10.15 Catalina or later (64-bit), and Linux (64-bit). 1.Install the latest version of Arduino integrated development environment (IDE): This protocol was tested using Arduino IDE 2.3.10. Newer compatible versions may also be used. Install the latest version of Arduino integrated development environment (IDE): This protocol was tested using Arduino IDE 2.3.10. Newer compatible versions may also be used. 2.Arduino IDE can be installed on Windows 10 or later (64-bit), macOS 10.15 Catalina or later (64-bit), and Linux (64-bit). Arduino IDE can be installed on Windows 10 or later (64-bit), macOS 10.15 Catalina or later (64-bit), and Linux (64-bit). Purchase items for the LED controller Timing: 2 weeks Timing: 2 weeks This section describes how to obtain the components for the LED controller.3.Prepare commercially available items listed in the key resources table (Figure 1).Figure 1List of major components used for the Arduino and LED system(A) Arduino.(B) Gravity: Easy Relay Module.(C) Male-to-male jumper wires.(D) Digital sensor cable.(E) Arduino case.(F) 470 nm LED.(G) 660 nm LED. 3.Prepare commercially available items listed in the key resources table (Figure 1).Figure 1List of major components used for the Arduino and LED system(A) Arduino.(B) Gravity: Easy Relay Module.(C) Male-to-male jumper wires.(D) Digital sensor cable.(E) Arduino case.(F) 470 nm LED.(G) 660 nm LED. Prepare commercially available items listed in the key resources table (Figure 1).Figure 1List of major components used for the Arduino and LED system(A) Arduino.(B) Gravity: Easy Relay Module.(C) Male-to-male jumper wires.(D) Digital sensor cable.(E) Arduino case.(F) 470 nm LED.(G) 660 nm LED. List of major components used for the Arduino and LED system (A) Arduino. (B) Gravity: Easy Relay Module. (C) Male-to-male jumper wires. (D) Digital sensor cable. (E) Arduino case. (F) 470 nm LED. (G) 660 nm LED. Assemble the LED controller Timing: 1 h Timing: 1 h This section describes how to connect the Arduino Uno, Gravity: Easy Relay Module, power supplies, and LED illumination unit.4.See Figure 2 to assemble the LED controller.a.Connect the three male-to-male jumper wires to the digital sensor cable (Figures 2A–2C).b.Pass the jumper wires through the opening in the Arduino case, with one wire on one side and two wires on the other side (Figure 2D).c.Connect the signal wire to digital pin 10 on the Arduino Uno (Figures 2E and 2F).d.Connect the remaining two wires to the 5 V and ground (GND) pins (Figures 2G and 2H).e.Tighten the screws and close the Arduino case (Figures 2I–2K).f.Connect the digital sensor cable to the Gravity: Easy Relay Module and set the relay switch to the normally closed (NC) position (Figure 2L).g.Connect the AC adapter providing a 24-V DC output to the VIN connector of the Gravity: Easy Relay Module, and connect the LED power cable to the VOUT connector (Figure 2M).h.Connect the power adapter to the Arduino controller. Connect the Arduino to a computer using a USB data cable only when uploading the program (Figures 2N and 2O).Figure 2Step-by-step assembly of the Arduino controller(A–C) Connect the jumper wires to the digital sensor cable.(D) Pass the jumper wires through the gap in the case, with one wire on one side and two wires on the other side.(E and F) Connect the jumper wire to digital pin 10 on the Arduino. Panel F shows a magnified view of the yellow box in (E). The green arrow indicates the connection to digital pin 10.(G and H) Connect the jumper wires to the 5 V and GND pins. Panel H shows a magnified view of the yellow box in (G). The green arrows indicate the connections to the 5 V and GND pins.(I–K) Tighten the screws and close the case.(L) Connect the digital sensor cable to the Gravity: Easy Relay Module. Make sure that the switch is set to “NC” (green arrow).(M) Connect the 24-V power supply to the VIN connector. Connect the LED unit to the VOUT connector.(N) Connect the 5-V power supply to the Arduino.(O) Connect the USB cable to the Arduino and a computer.Note: In Figure 2L, make sure that the switch is set to “NC”.Note: Power the LEDB-SBOXHP with the 24-V DC, 0.5-A adapter and the Arduino Uno with the 5-V DC, 1.0-A adapter.CRITICAL: Do not interchange the LED and Arduino adapters.Note: Arduino recommends a 7–12-V input when the Arduino Uno is powered through its DC barrel jack. The regulated 5-V, 1.0-A adapter used in these experiments operated normally. If instability occurs, use a regulated 7–12-V, center-positive adapter compatible with the Arduino Uno barrel jack.Note: In Figure 2M, the adapter is connected to the VIN side. The LED is connected to the VOUT side. Make sure that the relay switch is set to the NC position.5.Confirm that the completed connections among the LED, Gravity: Easy Relay Module, and Arduino match Figure 3.Figure 3Arduino-controlled LED stimulation systemThe assembled (A) circuit and (B) devices.Note: A computer is connected only when the Arduino program is uploaded. 4.See Figure 2 to assemble the LED controller.a.Connect the three male-to-male jumper wires to the digital sensor cable (Figures 2A–2C).b.Pass the jumper wires through the opening in the Arduino case, with one wire on one side and two wires on the other side (Figure 2D).c.Connect the signal wire to digital pin 10 on the Arduino Uno (Figures 2E and 2F).d.Connect the remaining two wires to the 5 V and ground (GND) pins (Figures 2G and 2H).e.Tighten the screws and close the Arduino case (Figures 2I–2K).f.Connect the digital sensor cable to the Gravity: Easy Relay Module and set the relay switch to the normally closed (NC) position (Figure 2L).g.Connect the AC adapter providing a 24-V DC output to the VIN connector of the Gravity: Easy Relay Module, and connect the LED power cable to the VOUT connector (Figure 2M).h.Connect the power adapter to the Arduino controller. Connect the Arduino to a computer using a USB data cable only when uploading the program (Figures 2N and 2O).Figure 2Step-by-step assembly of the Arduino controller(A–C) Connect the jumper wires to the digital sensor cable.(D) Pass the jumper wires through the gap in the case, with one wire on one side and two wires on the other side.(E and F) Connect the jumper wire to digital pin 10 on the Arduino. Panel F shows a magnified view of the yellow box in (E). The green arrow indicates the connection to digital pin 10.(G and H) Connect the jumper wires to the 5 V and GND pins. Panel H shows a magnified view of the yellow box in (G). The green arrows indicate the connections to the 5 V and GND pins.(I–K) Tighten the screws and close the case.(L) Connect the digital sensor cable to the Gravity: Easy Relay Module. Make sure that the switch is set to “NC” (green arrow).(M) Connect the 24-V power supply to the VIN connector. Connect the LED unit to the VOUT connector.(N) Connect the 5-V power supply to the Arduino.(O) Connect the USB cable to the Arduino and a computer. See Figure 2 to assemble the LED controller.a.Connect the three male-to-male jumper wires to the digital sensor cable (Figures 2A–2C).b.Pass the jumper wires through the opening in the Arduino case, with one wire on one side and two wires on the other side (Figure 2D).c.Connect the signal wire to digital pin 10 on the Arduino Uno (Figures 2E and 2F).d.Connect the remaining two wires to the 5 V and ground (GND) pins (Figures 2G and 2H).e.Tighten the screws and close the Arduino case (Figures 2I–2K).f.Connect the digital sensor cable to the Gravity: Easy Relay Module and set the relay switch to the normally closed (NC) position (Figure 2L).g.Connect the AC adapter providing a 24-V DC output to the VIN connector of the Gravity: Easy Relay Module, and connect the LED power cable to the VOUT connector (Figure 2M).h.Connect the power adapter to the Arduino controller. Connect the Arduino to a computer using a USB data cable only when uploading the program (Figures 2N and 2O).Figure 2Step-by-step assembly of the Arduino controller(A–C) Connect the jumper wires to the digital sensor cable.(D) Pass the jumper wires through the gap in the case, with one wire on one side and two wires on the other side.(E and F) Connect the jumper wire to digital pin 10 on the Arduino. Panel F shows a magnified view of the yellow box in (E). The green arrow indicates the connection to digital pin 10.(G and H) Connect the jumper wires to the 5 V and GND pins. Panel H shows a magnified view of the yellow box in (G). The green arrows indicate the connections to the 5 V and GND pins.(I–K) Tighten the screws and close the case.(L) Connect the digital sensor cable to the Gravity: Easy Relay Module. Make sure that the switch is set to “NC” (green arrow).(M) Connect the 24-V power supply to the VIN connector. Connect the LED unit to the VOUT connector.(N) Connect the 5-V power supply to the Arduino.(O) Connect the USB cable to the Arduino and a computer. a.Connect the three male-to-male jumper wires to the digital sensor cable (Figures 2A–2C). Connect the three male-to-male jumper wires to the digital sensor cable (Figures 2A–2C). b.Pass the jumper wires through the opening in the Arduino case, with one wire on one side and two wires on the other side (Figure 2D). Pass the jumper wires through the opening in the Arduino case, with one wire on one side and two wires on the other side (Figure 2D). c.Connect the signal wire to digital pin 10 on the Arduino Uno (Figures 2E and 2F). Connect the signal wire to digital pin 10 on the Arduino Uno (Figures 2E and 2F). d.Connect the remaining two wires to the 5 V and ground (GND) pins (Figures 2G and 2H). Connect the remaining two wires to the 5 V and ground (GND) pins (Figures 2G and 2H). e.Tighten the screws and close the Arduino case (Figures 2I–2K). Tighten the screws and close the Arduino case (Figures 2I–2K). f.Connect the digital sensor cable to the Gravity: Easy Relay Module and set the relay switch to the normally closed (NC) position (Figure 2L). Connect the digital sensor cable to the Gravity: Easy Relay Module and set the relay switch to the normally closed (NC) position (Figure 2L). g.Connect the AC adapter providing a 24-V DC output to the VIN connector of the Gravity: Easy Relay Module, and connect the LED power cable to the VOUT connector (Figure 2M). Connect the AC adapter providing a 24-V DC output to the VIN connector of the Gravity: Easy Relay Module, and connect the LED power cable to the VOUT connector (Figure 2M). h.Connect the power adapter to the Arduino controller. Connect the Arduino to a computer using a USB data cable only when uploading the program (Figures 2N and 2O). Connect the power adapter to the Arduino controller. Connect the Arduino to a computer using a USB data cable only when uploading the program (Figures 2N and 2O). Step-by-step assembly of the Arduino controller (A–C) Connect the jumper wires to the digital sensor cable. (D) Pass the jumper wires through the gap in the case, with one wire on one side and two wires on the other side. (E and F) Connect the jumper wire to digital pin 10 on the Arduino. Panel F shows a magnified view of the yellow box in (E). The green arrow indicates the connection to digital pin 10. (G and H) Connect the jumper wires to the 5 V and GND pins. Panel H shows a magnified view of the yellow box in (G). The green arrows indicate the connections to the 5 V and GND pins. (I–K) Tighten the screws and close the case. (L) Connect the digital sensor cable to the Gravity: Easy Relay Module. Make sure that the switch is set to “NC” (green arrow). (M) Connect the 24-V power supply to the VIN connector. Connect the LED unit to the VOUT connector. (N) Connect the 5-V power supply to the Arduino. (O) Connect the USB cable to the Arduino and a computer. Note: In Figure 2L, make sure that the switch is set to “NC”. Note: Power the LEDB-SBOXHP with the 24-V DC, 0.5-A adapter and the Arduino Uno with the 5-V DC, 1.0-A adapter. CRITICAL: Do not interchange the LED and Arduino adapters. Note: Arduino recommends a 7–12-V input when the Arduino Uno is powered through its DC barrel jack. The regulated 5-V, 1.0-A adapter used in these experiments operated normally. If instability occurs, use a regulated 7–12-V, center-positive adapter compatible with the Arduino Uno barrel jack. Note: In Figure 2M, the adapter is connected to the VIN side. The LED is connected to the VOUT side. Make sure that the relay switch is set to the NC position. 5.Confirm that the completed connections among the LED, Gravity: Easy Relay Module, and Arduino match Figure 3.Figure 3Arduino-controlled LED stimulation systemThe assembled (A) circuit and (B) devices. Confirm that the completed connections among the LED, Gravity: Easy Relay Module, and Arduino match Figure 3.Figure 3Arduino-controlled LED stimulation systemThe assembled (A) circuit and (B) devices. Arduino-controlled LED stimulation system The assembled (A) circuit and (B) devices. Note: A computer is connected only when the Arduino program is uploaded. Write the program Timing: 1 h Timing: 1 h This section describes how to create and upload the Arduino sketch used to control the illumination cycle.6.Open Arduino IDE and create a new sketch (File > New Sketch). Write the program as shown in Figure 4 and in the code box below for a 100 ms ON and 2 min OFF cycle.a.Connect the Arduino Uno to the computer with a data-capable USB cable.b.In the board selector, select “Arduino Uno”.Note: The port corresponding to the connected board is selected automatically. If the port is not selected automatically, select the connected Arduino Uno under Tools > Port.c.Click the “Verify” button to compile the sketch, and then click the “Upload” button (Figure 4).Note: Uploading takes a few seconds.d.To change the program, change the values of “ON_MILLISECOND” and/or “OFF_MILLISECOND”.Figure 4Arduino code used in the current study(A) Example code for 100 ms on and 2 min off.(B and C) LED OFF and ON states.Note: These values are in ms.const uint8_t OUTPUT_PIN = 10;const unsigned long ON_MILLISECOND = 100UL;const unsigned long OFF_MILLISECOND = 120000UL;void setup() {pinMode(OUTPUT_PIN, OUTPUT);}void loop() {digitalWrite(OUTPUT_PIN, HIGH);delay(ON_MILLISECOND);digitalWrite(OUTPUT_PIN, LOW);delay(OFF_MILLISECOND);}Pause point: After the sketch has been uploaded successfully, disconnect the USB cable. The programmed Arduino can be used later without reconnecting it to the computer. 6.Open Arduino IDE and create a new sketch (File > New Sketch). Write the program as shown in Figure 4 and in the code box below for a 100 ms ON and 2 min OFF cycle.a.Connect the Arduino Uno to the computer with a data-capable USB cable.b.In the board selector, select “Arduino Uno”.Note: The port corresponding to the connected board is selected automatically. If the port is not selected automatically, select the connected Arduino Uno under Tools > Port.c.Click the “Verify” button to compile the sketch, and then click the “Upload” button (Figure 4).Note: Uploading takes a few seconds.d.To change the program, change the values of “ON_MILLISECOND” and/or “OFF_MILLISECOND”.Figure 4Arduino code used in the current study(A) Example code for 100 ms on and 2 min off.(B and C) LED OFF and ON states. Open Arduino IDE and create a new sketch (File > New Sketch). Write the program as shown in Figure 4 and in the code box below for a 100 ms ON and 2 min OFF cycle.a.Connect the Arduino Uno to the computer with a data-capable USB cable.b.In the board selector, select “Arduino Uno”.Note: The port corresponding to the connected board is selected automatically. If the port is not selected automatically, select the connected Arduino Uno under Tools > Port.c.Click the “Verify” button to compile the sketch, and then click the “Upload” button (Figure 4).Note: Uploading takes a few seconds.d.To change the program, change the values of “ON_MILLISECOND” and/or “OFF_MILLISECOND”.Figure 4Arduino code used in the current study(A) Example code for 100 ms on and 2 min off.(B and C) LED OFF and ON states. a.Connect the Arduino Uno to the computer with a data-capable USB cable. Connect the Arduino Uno to the computer with a data-capable USB cable. b.In the board selector, select “Arduino Uno”.Note: The port corresponding to the connected board is selected automatically. If the port is not selected automatically, select the connected Arduino Uno under Tools > Port. In the board selector, select “Arduino Uno”.Note: The port corresponding to the connected board is selected automatically. If the port is not selected automatically, select the connected Arduino Uno under Tools > Port. Note: The port corresponding to the connected board is selected automatically. If the port is not selected automatically, select the connected Arduino Uno under Tools > Port. c.Click the “Verify” button to compile the sketch, and then click the “Upload” button (Figure 4).Note: Uploading takes a few seconds. Click the “Verify” button to compile the sketch, and then click the “Upload” button (Figure 4).Note: Uploading takes a few seconds. Note: Uploading takes a few seconds. d.To change the program, change the values of “ON_MILLISECOND” and/or “OFF_MILLISECOND”. To change the program, change the values of “ON_MILLISECOND” and/or “OFF_MILLISECOND”. Arduino code used in the current study (A) Example code for 100 ms on and 2 min off. (B and C) LED OFF and ON states. Note: These values are in ms. const uint8_t OUTPUT_PIN = 10; const unsigned long ON_MILLISECOND = 100UL; const unsigned long OFF_MILLISECOND = 120000UL; void setup() { pinMode(OUTPUT_PIN, OUTPUT); } void loop() { digitalWrite(OUTPUT_PIN, HIGH); delay(ON_MILLISECOND); digitalWrite(OUTPUT_PIN, LOW); delay(OFF_MILLISECOND); } Pause point: After the sketch has been uploaded successfully, disconnect the USB cable. The programmed Arduino can be used later without reconnecting it to the computer. Generate GPR161 knockout iPS cells using CRISPR-Cas9 Timing: 3–4 weeks Timing: 1 h (step 7) Timing: 1 h (step 8) Timing: 3–4 weeks (step 9) Timing: 3–4 weeks Timing: 1 h (step 7) Timing: 1 h (step 8) Timing: 3–4 weeks (step 9) In this section, we describe a protocol to generate GPR161 KO iPS cells using CRISPR/Cas9. GPR161 KO iPS cells will be used for generation of cells for optogenetic experiments.Note: Before you begin, culture iPS cells in a 35 mm dish with StemFit and iMatrix until they reach 60–70% confluency (about 4–7 days). iPS cells were routinely passaged every 5–7 days at 625–1,250 cells/cm2 and treated with 10 μM Y-27632 for the first 24 h after passaging. Please note that the optimal cell density depends on the iPS cell lines. For a 35 mm dish, use 1 ml of StemFit and 4 μl of iMatrix. Add iMatrix directly to the culture medium at 0.2 μg/cm2 without pre-coating the dish.7.Generate the CRISPR/Cas9 Ribonucleoprotein (RNP) complex.a.Mix 2 μl of ATTO 550-labeled tracrRNA (100 μM) and 2 μl of GPR161 crRNA (100 μM).Note: The GPR161 crRNA sequence is listed in the key resources table.b.Incubate these RNAs at 95°C for 5 min, then allow them to cool to 20–25°C.c.Add 1 μl of HiFi Cas9 nuclease v3 (10 mg/ml) to the RNAs to generate the RNP complex.d.Incubate at 20–25°C for 30 min in the dark.e.During this 30 min incubation, prepare the cells for electroporation.Note: Mix the solution by pipetting, not by vortex.Note: For electroporation, use actively proliferating cells, which give higher efficiency of ATTO 550-positive cells. The cells are not separately stained with ATTO 550. ATTO 550 is covalently attached to the purchased tracrRNA. The ATTO 550-tracrRNA hybridizes with the target-specific crRNA to form the guide RNA and is incorporated into the Cas9 RNP complex. An ATTO 550-positive signal after electroporation is used as an indicator of intracellular delivery of the labeled RNP complex; it does not by itself demonstrate successful genome editing.8.Prepare iPS cells for electroporation.a.Aspirate the culture medium and add 0.5 ml ethylenediaminetetraacetic acid (EDTA) solution in phosphate-buffered saline (PBS) to the dish.Note: If the iPS cells have been cultured for longer than seven days, incubate them with EDTA for 1 min at 37°C, then gently aspirate the EDTA and proceed to the next step.b.Immediately aspirate the EDTA solution and add 0.4 ml TrypLE/EDTA solution to the dish.c.Incubate at 37°C for 5 min in a CO2 incubator.d.Transfer the cell suspension to a 1.5 ml tube. Rinse the dish twice with 0.5 ml Dulbecco’s Modified Eagle Medium (DMEM)/F12 and collect the rinses into the same 1.5 ml tube.Note: Use pipetting to detach cells remaining on the dish, then transfer them. Excessive pipetting may damage the cells.e.Centrifuge at 190 × g for 3 min and collect the pellet.f.Resuspend it in 0.5 ml DMEM/F12 and count the number of cells.Note: Use a swinging-bucket centrifuge and centrifuge at 190 × g for 3 min.g.Transfer a volume containing 3 × 105 cells to a new 1.5 ml tube. The required volume depends on the cell density. Centrifuge the tube at 190 × g for 3 min and aspirate the supernatant. Use the resulting cell pellet in the next step.Note: A 35 mm dish at approximately 60–70% confluency generally provides enough cells for two to four nucleofection experiments using 3 × 105 cells per nucleofection. The remaining cells can be used for additional nucleofection experiments or discarded.h.Resuspend the cell pellet in 100 μl of nucleofection solution containing the GPR161 CRISPR/Cas9 RNP complex.i.Transfer the solution to a nucleofection cuvette. Electroporate using Nucleofector 2b program B-016.j.Immediately recover the cells in 5 ml DMEM/F12 in a 15 ml tube, then centrifuge at 190 × g for 3 min and aspirate the supernatant.k.Resuspend the cells in 1 ml of StemFit with 1 μl of Y-27632 (10 μM final concentration), then culture them in a 35 mm dish with iMatrix.9.Isolate single iPS cells by FACS sorting and expand the resulting clones to establish a GPR161 KO line.a.The next day, collect the cells using EDTA solution followed by TrypLE/EDTA solution, and resuspend them in StemFit with Y-27632 (10 μM) and 4′,6-diamidino-2-phenylindole (DAPI; 1:500).Note: Because the ATTO 550 signal may decrease over time, we recommend minimal observation under a fluorescence microscope before cell collection.b.Isolate viable ATTO 550-positive cells using a FACSAria III sorter (Figure 5).i.Gate the cell population based on Forward scatter (FSC)-Area and Side scatter (SSC)-Area to exclude debris.ii.Select singlets using FSC-Area and FSC-Width and exclude DAPI-positive dead cells.iii.Define the ATTO 550-positive gate using non-transfected iPSCs stained with DAPI as a negative control and select DAPI-negative, ATTO 550-positive cells.Note: The commercially purchased tracrRNA was covalently labeled with ATTO 550 and was introduced into the cells during electroporation as part of the Cas9 RNP complex. ATTO 550-positive cells were isolated to enrich for cells that had received the genome-editing reagents.Note: About 1–10% of cells are ATTO 550-positive.Note: Prepare a tube containing non-transfected iPS cells stained with DAPI as a negative control for ATTO 550.Figure 5Flow cytometry plots showing the gating strategy for human iPS cells(A–C) Sequential gating of cells, singlets, and viable DAPI-negative iPS cells.(D and E) Detection of ATTO 550-labeled tracrRNA after electroporation in non-transfected iPS and ATTO 550-tracrRNA-electroporated cells, respectively.(F) Detection of GFP in GPR161 KO cells following lipofectamine-mediated transfection with pAAVS1-CAG-Arl13b-bPACF198Y-EGFP. Two peaks were observed, and the population with high GFP fluorescence was considered GFP-positive.c.Isolate individual clones using either of the following methods.i.Sort one cell into each well of a 96-well plate and culture for 7 days.Note: In our experience, the survival efficiency is about 10–20%, so if many clones are needed, prepare 5–10 96-well plates.Note: Because the volumes of iMatrix and Y-27632 required for each well are too small to pipette accurately, prepare 1 ml of StemFit containing 1 μl of Y-27632 and 1.2 μl of iMatrix for up to nine wells of a 96-well plate. Dispense 100 μl into each well before sorting. The remaining 100 μl compensates for pipetting loss. If more than nine wells are required, scale all components proportionally.ii.Alternatively, sort 100 cells into a 1.5 ml tube with 500 μl of StemFit supplemented with Y-27632 (10 μM), and seed the cells onto a 35 mm dish containing 1 ml of StemFit supplemented with Y-27632 and iMatrix.Note: This seeding density allows colonies to be manually picked after 4–6 days of culture. Before picking, treat the colonies with 1 ml of 0.5 mM EDTA for 1 min.d.During the 7-day culture period, use a microscope to identify surviving clones.e.Harvest approximately half of the cells from each clone with a 200 μl pipette tip for genomic DNA extraction, while retaining the remaining cells for expansion.f.Perform Sanger sequencing and identify the GPR161 KO iPS clone.Note: The efficiency of obtaining KO lines depends on the guide RNA (gRNA). Analysis of 20 clones without identification of an edit at the target site may indicate low gRNA editing efficiency. In this case, we recommend designing a new gRNA targeting a different sequence, if possible.g.Expand the desired clone and freeze for future use.Pause point: The established GPR161 KO iPS cell line can be cryopreserved at this stage. Note: Before you begin, culture iPS cells in a 35 mm dish with StemFit and iMatrix until they reach 60–70% confluency (about 4–7 days). iPS cells were routinely passaged every 5–7 days at 625–1,250 cells/cm2 and treated with 10 μM Y-27632 for the first 24 h after passaging. Please note that the optimal cell density depends on the iPS cell lines. For a 35 mm dish, use 1 ml of StemFit and 4 μl of iMatrix. Add iMatrix directly to the culture medium at 0.2 μg/cm2 without pre-coating the dish. 7.Generate the CRISPR/Cas9 Ribonucleoprotein (RNP) complex.a.Mix 2 μl of ATTO 550-labeled tracrRNA (100 μM) and 2 μl of GPR161 crRNA (100 μM).Note: The GPR161 crRNA sequence is listed in the key resources table.b.Incubate these RNAs at 95°C for 5 min, then allow them to cool to 20–25°C.c.Add 1 μl of HiFi Cas9 nuclease v3 (10 mg/ml) to the RNAs to generate the RNP complex.d.Incubate at 20–25°C for 30 min in the dark.e.During this 30 min incubation, prepare the cells for electroporation.Note: Mix the solution by pipetting, not by vortex.Note: For electroporation, use actively proliferating cells, which give higher efficiency of ATTO 550-positive cells. The cells are not separately stained with ATTO 550. ATTO 550 is covalently attached to the purchased tracrRNA. The ATTO 550-tracrRNA hybridizes with the target-specific crRNA to form the guide RNA and is incorporated into the Cas9 RNP complex. An ATTO 550-positive signal after electroporation is used as an indicator of intracellular delivery of the labeled RNP complex; it does not by itself demonstrate successful genome editing. Generate the CRISPR/Cas9 Ribonucleoprotein (RNP) complex.a.Mix 2 μl of ATTO 550-labeled tracrRNA (100 μM) and 2 μl of GPR161 crRNA (100 μM).Note: The GPR161 crRNA sequence is listed in the key resources table.b.Incubate these RNAs at 95°C for 5 min, then allow them to cool to 20–25°C.c.Add 1 μl of HiFi Cas9 nuclease v3 (10 mg/ml) to the RNAs to generate the RNP complex.d.Incubate at 20–25°C for 30 min in the dark.e.During this 30 min incubation, prepare the cells for electroporation.Note: Mix the solution by pipetting, not by vortex.Note: For electroporation, use actively proliferating cells, which give higher efficiency of ATTO 550-positive cells. The cells are not separately stained with ATTO 550. ATTO 550 is covalently attached to the purchased tracrRNA. The ATTO 550-tracrRNA hybridizes with the target-specific crRNA to form the guide RNA and is incorporated into the Cas9 RNP complex. An ATTO 550-positive signal after electroporation is used as an indicator of intracellular delivery of the labeled RNP complex; it does not by itself demonstrate successful genome editing. a.Mix 2 μl of ATTO 550-labeled tracrRNA (100 μM) and 2 μl of GPR161 crRNA (100 μM).Note: The GPR161 crRNA sequence is listed in the key resources table. Mix 2 μl of ATTO 550-labeled tracrRNA (100 μM) and 2 μl of GPR161 crRNA (100 μM).Note: The GPR161 crRNA sequence is listed in the key resources table. Note: The GPR161 crRNA sequence is listed in the key resources table. b.Incubate these RNAs at 95°C for 5 min, then allow them to cool to 20–25°C. Incubate these RNAs at 95°C for 5 min, then allow them to cool to 20–25°C. c.Add 1 μl of HiFi Cas9 nuclease v3 (10 mg/ml) to the RNAs to generate the RNP complex. Add 1 μl of HiFi Cas9 nuclease v3 (10 mg/ml) to the RNAs to generate the RNP complex. d.Incubate at 20–25°C for 30 min in the dark. Incubate at 20–25°C for 30 min in the dark. e.During this 30 min incubation, prepare the cells for electroporation.Note: Mix the solution by pipetting, not by vortex.Note: For electroporation, use actively proliferating cells, which give higher efficiency of ATTO 550-positive cells. The cells are not separately stained with ATTO 550. ATTO 550 is covalently attached to the purchased tracrRNA. The ATTO 550-tracrRNA hybridizes with the target-specific crRNA to form the guide RNA and is incorporated into the Cas9 RNP complex. An ATTO 550-positive signal after electroporation is used as an indicator of intracellular delivery of the labeled RNP complex; it does not by itself demonstrate successful genome editing. During this 30 min incubation, prepare the cells for electroporation.Note: Mix the solution by pipetting, not by vortex.Note: For electroporation, use actively proliferating cells, which give higher efficiency of ATTO 550-positive cells. The cells are not separately stained with ATTO 550. ATTO 550 is covalently attached to the purchased tracrRNA. The ATTO 550-tracrRNA hybridizes with the target-specific crRNA to form the guide RNA and is incorporated into the Cas9 RNP complex. An ATTO 550-positive signal after electroporation is used as an indicator of intracellular delivery of the labeled RNP complex; it does not by itself demonstrate successful genome editing. Note: Mix the solution by pipetting, not by vortex. Note: For electroporation, use actively proliferating cells, which give higher efficiency of ATTO 550-positive cells. The cells are not separately stained with ATTO 550. ATTO 550 is covalently attached to the purchased tracrRNA. The ATTO 550-tracrRNA hybridizes with the target-specific crRNA to form the guide RNA and is incorporated into the Cas9 RNP complex. An ATTO 550-positive signal after electroporation is used as an indicator of intracellular delivery of the labeled RNP complex; it does not by itself demonstrate successful genome editing. 8.Prepare iPS cells for electroporation.a.Aspirate the culture medium and add 0.5 ml ethylenediaminetetraacetic acid (EDTA) solution in phosphate-buffered saline (PBS) to the dish.Note: If the iPS cells have been cultured for longer than seven days, incubate them with EDTA for 1 min at 37°C, then gently aspirate the EDTA and proceed to the next step.b.Immediately aspirate the EDTA solution and add 0.4 ml TrypLE/EDTA solution to the dish.c.Incubate at 37°C for 5 min in a CO2 incubator.d.Transfer the cell suspension to a 1.5 ml tube. Rinse the dish twice with 0.5 ml Dulbecco’s Modified Eagle Medium (DMEM)/F12 and collect the rinses into the same 1.5 ml tube.Note: Use pipetting to detach cells remaining on the dish, then transfer them. Excessive pipetting may damage the cells.e.Centrifuge at 190 × g for 3 min and collect the pellet.f.Resuspend it in 0.5 ml DMEM/F12 and count the number of cells.Note: Use a swinging-bucket centrifuge and centrifuge at 190 × g for 3 min.g.Transfer a volume containing 3 × 105 cells to a new 1.5 ml tube. The required volume depends on the cell density. Centrifuge the tube at 190 × g for 3 min and aspirate the supernatant. Use the resulting cell pellet in the next step.Note: A 35 mm dish at approximately 60–70% confluency generally provides enough cells for two to four nucleofection experiments using 3 × 105 cells per nucleofection. The remaining cells can be used for additional nucleofection experiments or discarded.h.Resuspend the cell pellet in 100 μl of nucleofection solution containing the GPR161 CRISPR/Cas9 RNP complex.i.Transfer the solution to a nucleofection cuvette. Electroporate using Nucleofector 2b program B-016.j.Immediately recover the cells in 5 ml DMEM/F12 in a 15 ml tube, then centrifuge at 190 × g for 3 min and aspirate the supernatant.k.Resuspend the cells in 1 ml of StemFit with 1 μl of Y-27632 (10 μM final concentration), then culture them in a 35 mm dish with iMatrix. Prepare iPS cells for electroporation.a.Aspirate the culture medium and add 0.5 ml ethylenediaminetetraacetic acid (EDTA) solution in phosphate-buffered saline (PBS) to the dish.Note: If the iPS cells have been cultured for longer than seven days, incubate them with EDTA for 1 min at 37°C, then gently aspirate the EDTA and proceed to the next step.b.Immediately aspirate the EDTA solution and add 0.4 ml TrypLE/EDTA solution to the dish.c.Incubate at 37°C for 5 min in a CO2 incubator.d.Transfer the cell suspension to a 1.5 ml tube. Rinse the dish twice with 0.5 ml Dulbecco’s Modified Eagle Medium (DMEM)/F12 and collect the rinses into the same 1.5 ml tube.Note: Use pipetting to detach cells remaining on the dish, then transfer them. Excessive pipetting may damage the cells.e.Centrifuge at 190 × g for 3 min and collect the pellet.f.Resuspend it in 0.5 ml DMEM/F12 and count the number of cells.Note: Use a swinging-bucket centrifuge and centrifuge at 190 × g for 3 min.g.Transfer a volume containing 3 × 105 cells to a new 1.5 ml tube. The required volume depends on the cell density. Centrifuge the tube at 190 × g for 3 min and aspirate the supernatant. Use the resulting cell pellet in the next step.Note: A 35 mm dish at approximately 60–70% confluency generally provides enough cells for two to four nucleofection experiments using 3 × 105 cells per nucleofection. The remaining cells can be used for additional nucleofection experiments or discarded.h.Resuspend the cell pellet in 100 μl of nucleofection solution containing the GPR161 CRISPR/Cas9 RNP complex.i.Transfer the solution to a nucleofection cuvette. Electroporate using Nucleofector 2b program B-016.j.Immediately recover the cells in 5 ml DMEM/F12 in a 15 ml tube, then centrifuge at 190 × g for 3 min and aspirate the supernatant.k.Resuspend the cells in 1 ml of StemFit with 1 μl of Y-27632 (10 μM final concentration), then culture them in a 35 mm dish with iMatrix. a.Aspirate the culture medium and add 0.5 ml ethylenediaminetetraacetic acid (EDTA) solution in phosphate-buffered saline (PBS) to the dish.Note: If the iPS cells have been cultured for longer than seven days, incubate them with EDTA for 1 min at 37°C, then gently aspirate the EDTA and proceed to the next step. Aspirate the culture medium and add 0.5 ml ethylenediaminetetraacetic acid (EDTA) solution in phosphate-buffered saline (PBS) to the dish.Note: If the iPS cells have been cultured for longer than seven days, incubate them with EDTA for 1 min at 37°C, then gently aspirate the EDTA and proceed to the next step. Note: If the iPS cells have been cultured for longer than seven days, incubate them with EDTA for 1 min at 37°C, then gently aspirate the EDTA and proceed to the next step. b.Immediately aspirate the EDTA solution and add 0.4 ml TrypLE/EDTA solution to the dish. Immediately aspirate the EDTA solution and add 0.4 ml TrypLE/EDTA solution to the dish. c.Incubate at 37°C for 5 min in a CO2 incubator. Incubate at 37°C for 5 min in a CO2 incubator. d.Transfer the cell suspension to a 1.5 ml tube. Rinse the dish twice with 0.5 ml Dulbecco’s Modified Eagle Medium (DMEM)/F12 and collect the rinses into the same 1.5 ml tube.Note: Use pipetting to detach cells remaining on the dish, then transfer them. Excessive pipetting may damage the cells. Transfer the cell suspension to a 1.5 ml tube. Rinse the dish twice with 0.5 ml Dulbecco’s Modified Eagle Medium (DMEM)/F12 and collect the rinses into the same 1.5 ml tube.Note: Use pipetting to detach cells remaining on the dish, then transfer them. Excessive pipetting may damage the cells. Note: Use pipetting to detach cells remaining on the dish, then transfer them. Excessive pipetting may damage the cells. e.Centrifuge at 190 × g for 3 min and collect the pellet. Centrifuge at 190 × g for 3 min and collect the pellet. f.Resuspend it in 0.5 ml DMEM/F12 and count the number of cells.Note: Use a swinging-bucket centrifuge and centrifuge at 190 × g for 3 min. Resuspend it in 0.5 ml DMEM/F12 and count the number of cells.Note: Use a swinging-bucket centrifuge and centrifuge at 190 × g for 3 min. Note: Use a swinging-bucket centrifuge and centrifuge at 190 × g for 3 min. g.Transfer a volume containing 3 × 105 cells to a new 1.5 ml tube. The required volume depends on the cell density. Centrifuge the tube at 190 × g for 3 min and aspirate the supernatant. Use the resulting cell pellet in the next step.Note: A 35 mm dish at approximately 60–70% confluency generally provides enough cells for two to four nucleofection experiments using 3 × 105 cells per nucleofection. The remaining cells can be used for additional nucleofection experiments or discarded. Transfer a volume containing 3 × 105 cells to a new 1.5 ml tube. The required volume depends on the cell density. Centrifuge the tube at 190 × g for 3 min and aspirate the supernatant. Use the resulting cell pellet in the next step.Note: A 35 mm dish at approximately 60–70% confluency generally provides enough cells for two to four nucleofection experiments using 3 × 105 cells per nucleofection. The remaining cells can be used for additional nucleofection experiments or discarded. Note: A 35 mm dish at approximately 60–70% confluency generally provides enough cells for two to four nucleofection experiments using 3 × 105 cells per nucleofection. The remaining cells can be used for additional nucleofection experiments or discarded. h.Resuspend the cell pellet in 100 μl of nucleofection solution containing the GPR161 CRISPR/Cas9 RNP complex. Resuspend the cell pellet in 100 μl of nucleofection solution containing the GPR161 CRISPR/Cas9 RNP complex. i.Transfer the solution to a nucleofection cuvette. Electroporate using Nucleofector 2b program B-016. Transfer the solution to a nucleofection cuvette. Electroporate using Nucleofector 2b program B-016. j.Immediately recover the cells in 5 ml DMEM/F12 in a 15 ml tube, then centrifuge at 190 × g for 3 min and aspirate the supernatant. Immediately recover the cells in 5 ml DMEM/F12 in a 15 ml tube, then centrifuge at 190 × g for 3 min and aspirate the supernatant. k.Resuspend the cells in 1 ml of StemFit with 1 μl of Y-27632 (10 μM final concentration), then culture them in a 35 mm dish with iMatrix. Resuspend the cells in 1 ml of StemFit with 1 μl of Y-27632 (10 μM final concentration), then culture them in a 35 mm dish with iMatrix. 9.Isolate single iPS cells by FACS sorting and expand the resulting clones to establish a GPR161 KO line.a.The next day, collect the cells using EDTA solution followed by TrypLE/EDTA solution, and resuspend them in StemFit with Y-27632 (10 μM) and 4′,6-diamidino-2-phenylindole (DAPI; 1:500).Note: Because the ATTO 550 signal may decrease over time, we recommend minimal observation under a fluorescence microscope before cell collection.b.Isolate viable ATTO 550-positive cells using a FACSAria III sorter (Figure 5).i.Gate the cell population based on Forward scatter (FSC)-Area and Side scatter (SSC)-Area to exclude debris.ii.Select singlets using FSC-Area and FSC-Width and exclude DAPI-positive dead cells.iii.Define the ATTO 550-positive gate using non-transfected iPSCs stained with DAPI as a negative control and select DAPI-negative, ATTO 550-positive cells.Note: The commercially purchased tracrRNA was covalently labeled with ATTO 550 and was introduced into the cells during electroporation as part of the Cas9 RNP complex. ATTO 550-positive cells were isolated to enrich for cells that had received the genome-editing reagents.Note: About 1–10% of cells are ATTO 550-positive.Note: Prepare a tube containing non-transfected iPS cells stained with DAPI as a negative control for ATTO 550.Figure 5Flow cytometry plots showing the gating strategy for human iPS cells(A–C) Sequential gating of cells, singlets, and viable DAPI-negative iPS cells.(D and E) Detection of ATTO 550-labeled tracrRNA after electroporation in non-transfected iPS and ATTO 550-tracrRNA-electroporated cells, respectively.(F) Detection of GFP in GPR161 KO cells following lipofectamine-mediated transfection with pAAVS1-CAG-Arl13b-bPACF198Y-EGFP. Two peaks were observed, and the population with high GFP fluorescence was considered GFP-positive.c.Isolate individual clones using either of the following methods.i.Sort one cell into each well of a 96-well plate and culture for 7 days.Note: In our experience, the survival efficiency is about 10–20%, so if many clones are needed, prepare 5–10 96-well plates.Note: Because the volumes of iMatrix and Y-27632 required for each well are too small to pipette accurately, prepare 1 ml of StemFit containing 1 μl of Y-27632 and 1.2 μl of iMatrix for up to nine wells of a 96-well plate. Dispense 100 μl into each well before sorting. The remaining 100 μl compensates for pipetting loss. If more than nine wells are required, scale all components proportionally.ii.Alternatively, sort 100 cells into a 1.5 ml tube with 500 μl of StemFit supplemented with Y-27632 (10 μM), and seed the cells onto a 35 mm dish containing 1 ml of StemFit supplemented with Y-27632 and iMatrix.Note: This seeding density allows colonies to be manually picked after 4–6 days of culture. Before picking, treat the colonies with 1 ml of 0.5 mM EDTA for 1 min.d.During the 7-day culture period, use a microscope to identify surviving clones.e.Harvest approximately half of the cells from each clone with a 200 μl pipette tip for genomic DNA extraction, while retaining the remaining cells for expansion.f.Perform Sanger sequencing and identify the GPR161 KO iPS clone.Note: The efficiency of obtaining KO lines depends on the guide RNA (gRNA). Analysis of 20 clones without identification of an edit at the target site may indicate low gRNA editing efficiency. In this case, we recommend designing a new gRNA targeting a different sequence, if possible.g.Expand the desired clone and freeze for future use.Pause point: The established GPR161 KO iPS cell line can be cryopreserved at this stage. Isolate single iPS cells by FACS sorting and expand the resulting clones to establish a GPR161 KO line.a.The next day, collect the cells using EDTA solution followed by TrypLE/EDTA solution, and resuspend them in StemFit with Y-27632 (10 μM) and 4′,6-diamidino-2-phenylindole (DAPI; 1:500).Note: Because the ATTO 550 signal may decrease over time, we recommend minimal observation under a fluorescence microscope before cell collection.b.Isolate viable ATTO 550-positive cells using a FACSAria III sorter (Figure 5).i.Gate the cell population based on Forward scatter (FSC)-Area and Side scatter (SSC)-Area to exclude debris.ii.Select singlets using FSC-Area and FSC-Width and exclude DAPI-positive dead cells.iii.Define the ATTO 550-positive gate using non-transfected iPSCs stained with DAPI as a negative control and select DAPI-negative, ATTO 550-positive cells.Note: The commercially purchased tracrRNA was covalently labeled with ATTO 550 and was introduced into the cells during electroporation as part of the Cas9 RNP complex. ATTO 550-positive cells were isolated to enrich for cells that had received the genome-editing reagents.Note: About 1–10% of cells are ATTO 550-positive.Note: Prepare a tube containing non-transfected iPS cells stained with DAPI as a negative control for ATTO 550.Figure 5Flow cytometry plots showing the gating strategy for human iPS cells(A–C) Sequential gating of cells, singlets, and viable DAPI-negative iPS cells.(D and E) Detection of ATTO 550-labeled tracrRNA after electroporation in non-transfected iPS and ATTO 550-tracrRNA-electroporated cells, respectively.(F) Detection of GFP in GPR161 KO cells following lipofectamine-mediated transfection with pAAVS1-CAG-Arl13b-bPACF198Y-EGFP. Two peaks were observed, and the population with high GFP fluorescence was considered GFP-positive.c.Isolate individual clones using either of the following methods.i.Sort one cell into each well of a 96-well plate and culture for 7 days.Note: In our experience, the survival efficiency is about 10–20%, so if many clones are needed, prepare 5–10 96-well plates.Note: Because the volumes of iMatrix and Y-27632 required for each well are too small to pipette accurately, prepare 1 ml of StemFit containing 1 μl of Y-27632 and 1.2 μl of iMatrix for up to nine wells of a 96-well plate. Dispense 100 μl into each well before sorting. The remaining 100 μl compensates for pipetting loss. If more than nine wells are required, scale all components proportionally.ii.Alternatively, sort 100 cells into a 1.5 ml tube with 500 μl of StemFit supplemented with Y-27632 (10 μM), and seed the cells onto a 35 mm dish containing 1 ml of StemFit supplemented with Y-27632 and iMatrix.Note: This seeding density allows colonies to be manually picked after 4–6 days of culture. Before picking, treat the colonies with 1 ml of 0.5 mM EDTA for 1 min.d.During the 7-day culture period, use a microscope to identify surviving clones.e.Harvest approximately half of the cells from each clone with a 200 μl pipette tip for genomic DNA extraction, while retaining the remaining cells for expansion.f.Perform Sanger sequencing and identify the GPR161 KO iPS clone.Note: The efficiency of obtaining KO lines depends on the guide RNA (gRNA). Analysis of 20 clones without identification of an edit at the target site may indicate low gRNA editing efficiency. In this case, we recommend designing a new gRNA targeting a different sequence, if possible.g.Expand the desired clone and freeze for future use.Pause point: The established GPR161 KO iPS cell line can be cryopreserved at this stage. a.The next day, collect the cells using EDTA solution followed by TrypLE/EDTA solution, and resuspend them in StemFit with Y-27632 (10 μM) and 4′,6-diamidino-2-phenylindole (DAPI; 1:500).Note: Because the ATTO 550 signal may decrease over time, we recommend minimal observation under a fluorescence microscope before cell collection. The next day, collect the cells using EDTA solution followed by TrypLE/EDTA solution, and resuspend them in StemFit with Y-27632 (10 μM) and 4′,6-diamidino-2-phenylindole (DAPI; 1:500).Note: Because the ATTO 550 signal may decrease over time, we recommend minimal observation under a fluorescence microscope before cell collection. Note: Because the ATTO 550 signal may decrease over time, we recommend minimal observation under a fluorescence microscope before cell collection. b.Isolate viable ATTO 550-positive cells using a FACSAria III sorter (Figure 5).i.Gate the cell population based on Forward scatter (FSC)-Area and Side scatter (SSC)-Area to exclude debris.ii.Select singlets using FSC-Area and FSC-Width and exclude DAPI-positive dead cells.iii.Define the ATTO 550-positive gate using non-transfected iPSCs stained with DAPI as a negative control and select DAPI-negative, ATTO 550-positive cells.Note: The commercially purchased tracrRNA was covalently labeled with ATTO 550 and was introduced into the cells during electroporation as part of the Cas9 RNP complex. ATTO 550-positive cells were isolated to enrich for cells that had received the genome-editing reagents.Note: About 1–10% of cells are ATTO 550-positive.Note: Prepare a tube containing non-transfected iPS cells stained with DAPI as a negative control for ATTO 550.Figure 5Flow cytometry plots showing the gating strategy for human iPS cells(A–C) Sequential gating of cells, singlets, and viable DAPI-negative iPS cells.(D and E) Detection of ATTO 550-labeled tracrRNA after electroporation in non-transfected iPS and ATTO 550-tracrRNA-electroporated cells, respectively.(F) Detection of GFP in GPR161 KO cells following lipofectamine-mediated transfection with pAAVS1-CAG-Arl13b-bPACF198Y-EGFP. Two peaks were observed, and the population with high GFP fluorescence was considered GFP-positive. Isolate viable ATTO 550-positive cells using a FACSAria III sorter (Figure 5).i.Gate the cell population based on Forward scatter (FSC)-Area and Side scatter (SSC)-Area to exclude debris.ii.Select singlets using FSC-Area and FSC-Width and exclude DAPI-positive dead cells.iii.Define the ATTO 550-positive gate using non-transfected iPSCs stained with DAPI as a negative control and select DAPI-negative, ATTO 550-positive cells.Note: The commercially purchased tracrRNA was covalently labeled with ATTO 550 and was introduced into the cells during electroporation as part of the Cas9 RNP complex. ATTO 550-positive cells were isolated to enrich for cells that had received the genome-editing reagents.Note: About 1–10% of cells are ATTO 550-positive.Note: Prepare a tube containing non-transfected iPS cells stained with DAPI as a negative control for ATTO 550.Figure 5Flow cytometry plots showing the gating strategy for human iPS cells(A–C) Sequential gating of cells, singlets, and viable DAPI-negative iPS cells.(D and E) Detection of ATTO 550-labeled tracrRNA after electroporation in non-transfected iPS and ATTO 550-tracrRNA-electroporated cells, respectively.(F) Detection of GFP in GPR161 KO cells following lipofectamine-mediated transfection with pAAVS1-CAG-Arl13b-bPACF198Y-EGFP. Two peaks were observed, and the population with high GFP fluorescence was considered GFP-positive. i.Gate the cell population based on Forward scatter (FSC)-Area and Side scatter (SSC)-Area to exclude debris. Gate the cell population based on Forward scatter (FSC)-Area and Side scatter (SSC)-Area to exclude debris. ii.Select singlets using FSC-Area and FSC-Width and exclude DAPI-positive dead cells. Select singlets using FSC-Area and FSC-Width and exclude DAPI-positive dead cells. iii.Define the ATTO 550-positive gate using non-transfected iPSCs stained with DAPI as a negative control and select DAPI-negative, ATTO 550-positive cells.Note: The commercially purchased tracrRNA was covalently labeled with ATTO 550 and was introduced into the cells during electroporation as part of the Cas9 RNP complex. ATTO 550-positive cells were isolated to enrich for cells that had received the genome-editing reagents.Note: About 1–10% of cells are ATTO 550-positive.Note: Prepare a tube containing non-transfected iPS cells stained with DAPI as a negative control for ATTO 550. Define the ATTO 550-positive gate using non-transfected iPSCs stained with DAPI as a negative control and select DAPI-negative, ATTO 550-positive cells.Note: The commercially purchased tracrRNA was covalently labeled with ATTO 550 and was introduced into the cells during electroporation as part of the Cas9 RNP complex. ATTO 550-positive cells were isolated to enrich for cells that had received the genome-editing reagents.Note: About 1–10% of cells are ATTO 550-positive.Note: Prepare a tube containing non-transfected iPS cells stained with DAPI as a negative control for ATTO 550. Note: The commercially purchased tracrRNA was covalently labeled with ATTO 550 and was introduced into the cells during electroporation as part of the Cas9 RNP complex. ATTO 550-positive cells were isolated to enrich for cells that had received the genome-editing reagents. Note: About 1–10% of cells are ATTO 550-positive. Note: Prepare a tube containing non-transfected iPS cells stained with DAPI as a negative control for ATTO 550. Flow cytometry plots showing the gating strategy for human iPS cells (A–C) Sequential gating of cells, singlets, and viable DAPI-negative iPS cells. (D and E) Detection of ATTO 550-labeled tracrRNA after electroporation in non-transfected iPS and ATTO 550-tracrRNA-electroporated cells, respectively. (F) Detection of GFP in GPR161 KO cells following lipofectamine-mediated transfection with pAAVS1-CAG-Arl13b-bPACF198Y-EGFP. Two peaks were observed, and the population with high GFP fluorescence was considered GFP-positive. c.Isolate individual clones using either of the following methods.i.Sort one cell into each well of a 96-well plate and culture for 7 days.Note: In our experience, the survival efficiency is about 10–20%, so if many clones are needed, prepare 5–10 96-well plates.Note: Because the volumes of iMatrix and Y-27632 required for each well are too small to pipette accurately, prepare 1 ml of StemFit containing 1 μl of Y-27632 and 1.2 μl of iMatrix for up to nine wells of a 96-well plate. Dispense 100 μl into each well before sorting. The remaining 100 μl compensates for pipetting loss. If more than nine wells are required, scale all components proportionally.ii.Alternatively, sort 100 cells into a 1.5 ml tube with 500 μl of StemFit supplemented with Y-27632 (10 μM), and seed the cells onto a 35 mm dish containing 1 ml of StemFit supplemented with Y-27632 and iMatrix.Note: This seeding density allows colonies to be manually picked after 4–6 days of culture. Before picking, treat the colonies with 1 ml of 0.5 mM EDTA for 1 min. Isolate individual clones using either of the following methods.i.Sort one cell into each well of a 96-well plate and culture for 7 days.Note: In our experience, the survival efficiency is about 10–20%, so if many clones are needed, prepare 5–10 96-well plates.Note: Because the volumes of iMatrix and Y-27632 required for each well are too small to pipette accurately, prepare 1 ml of StemFit containing 1 μl of Y-27632 and 1.2 μl of iMatrix for up to nine wells of a 96-well plate. Dispense 100 μl into each well before sorting. The remaining 100 μl compensates for pipetting loss. If more than nine wells are required, scale all components proportionally.ii.Alternatively, sort 100 cells into a 1.5 ml tube with 500 μl of StemFit supplemented with Y-27632 (10 μM), and seed the cells onto a 35 mm dish containing 1 ml of StemFit supplemented with Y-27632 and iMatrix.Note: This seeding density allows colonies to be manually picked after 4–6 days of culture. Before picking, treat the colonies with 1 ml of 0.5 mM EDTA for 1 min. i.Sort one cell into each well of a 96-well plate and culture for 7 days.Note: In our experience, the survival efficiency is about 10–20%, so if many clones are needed, prepare 5–10 96-well plates.Note: Because the volumes of iMatrix and Y-27632 required for each well are too small to pipette accurately, prepare 1 ml of StemFit containing 1 μl of Y-27632 and 1.2 μl of iMatrix for up to nine wells of a 96-well plate. Dispense 100 μl into each well before sorting. The remaining 100 μl compensates for pipetting loss. If more than nine wells are required, scale all components proportionally. Sort one cell into each well of a 96-well plate and culture for 7 days.Note: In our experience, the survival efficiency is about 10–20%, so if many clones are needed, prepare 5–10 96-well plates.Note: Because the volumes of iMatrix and Y-27632 required for each well are too small to pipette accurately, prepare 1 ml of StemFit containing 1 μl of Y-27632 and 1.2 μl of iMatrix for up to nine wells of a 96-well plate. Dispense 100 μl into each well before sorting. The remaining 100 μl compensates for pipetting loss. If more than nine wells are required, scale all components proportionally. Note: In our experience, the survival efficiency is about 10–20%, so if many clones are needed, prepare 5–10 96-well plates. Note: Because the volumes of iMatrix and Y-27632 required for each well are too small to pipette accurately, prepare 1 ml of StemFit containing 1 μl of Y-27632 and 1.2 μl of iMatrix for up to nine wells of a 96-well plate. Dispense 100 μl into each well before sorting. The remaining 100 μl compensates for pipetting loss. If more than nine wells are required, scale all components proportionally. ii.Alternatively, sort 100 cells into a 1.5 ml tube with 500 μl of StemFit supplemented with Y-27632 (10 μM), and seed the cells onto a 35 mm dish containing 1 ml of StemFit supplemented with Y-27632 and iMatrix.Note: This seeding density allows colonies to be manually picked after 4–6 days of culture. Before picking, treat the colonies with 1 ml of 0.5 mM EDTA for 1 min. Alternatively, sort 100 cells into a 1.5 ml tube with 500 μl of StemFit supplemented with Y-27632 (10 μM), and seed the cells onto a 35 mm dish containing 1 ml of StemFit supplemented with Y-27632 and iMatrix.Note: This seeding density allows colonies to be manually picked after 4–6 days of culture. Before picking, treat the colonies with 1 ml of 0.5 mM EDTA for 1 min. Note: This seeding density allows colonies to be manually picked after 4–6 days of culture. Before picking, treat the colonies with 1 ml of 0.5 mM EDTA for 1 min. d.During the 7-day culture period, use a microscope to identify surviving clones. During the 7-day culture period, use a microscope to identify surviving clones. e.Harvest approximately half of the cells from each clone with a 200 μl pipette tip for genomic DNA extraction, while retaining the remaining cells for expansion. Harvest approximately half of the cells from each clone with a 200 μl pipette tip for genomic DNA extraction, while retaining the remaining cells for expansion. f.Perform Sanger sequencing and identify the GPR161 KO iPS clone.Note: The efficiency of obtaining KO lines depends on the guide RNA (gRNA). Analysis of 20 clones without identification of an edit at the target site may indicate low gRNA editing efficiency. In this case, we recommend designing a new gRNA targeting a different sequence, if possible. Perform Sanger sequencing and identify the GPR161 KO iPS clone.Note: The efficiency of obtaining KO lines depends on the guide RNA (gRNA). Analysis of 20 clones without identification of an edit at the target site may indicate low gRNA editing efficiency. In this case, we recommend designing a new gRNA targeting a different sequence, if possible. Note: The efficiency of obtaining KO lines depends on the guide RNA (gRNA). Analysis of 20 clones without identification of an edit at the target site may indicate low gRNA editing efficiency. In this case, we recommend designing a new gRNA targeting a different sequence, if possible. g.Expand the desired clone and freeze for future use.Pause point: The established GPR161 KO iPS cell line can be cryopreserved at this stage. Expand the desired clone and freeze for future use.Pause point: The established GPR161 KO iPS cell line can be cryopreserved at this stage. Pause point: The established GPR161 KO iPS cell line can be cryopreserved at this stage. Generate cells for optogenetics Timing: 3–4 weeks Timing: 3–4 weeks In this section, we describe how to insert a bPACF198Y-enhanced green fluorescent protein (EGFP) fusion construct into the AAVS1 locus of iPS cells using CRISPR/Cas9. GPR161 KO iPS cells will be used for generation of cells for optogenetics. bPACF198Y is used instead of bPAC because it has lower activity in the dark. We also use primary cilium-targeted bPACF198Y-EGFP and cytoplasm-targeted bPACF198Y-EGFP to analyze the effects of cAMP production in primary cilia and the cytoplasm.10.Generate bPACF198Y-EGFP-expressing GPR161 KO iPS cells for optogeneticsa.Seed 6,000 GPR161 KO iPS cells in a 24-well plate.b.The next day, transfect the cells with the plasmids using Lipofectamine Stem Transfection Reagent.Note: For each well of a 24-well plate, dilute 1 μl of Lipofectamine Stem Transfection Reagent in 25 μl of Opti-MEM™ I Reduced Serum Medium. Separately, dilute 250 ng of pAAVS1-CAG-bPACF198Y-EGFP or pAAVS1-CAG-Arl13b-bPACF198Y-EGFP, together with 250 ng of pXAT2, in 25 μl of Opti-MEM™ I Reduced Serum Medium. Combine the two solutions, vortex for 2–3 s, and incubate at 20–25°C for 10 min. Add the resulting transfection mixture dropwise to the cells in the 24-well plate. The pAAVS1 vector and pXAT2 are used to target the AAVS1 locus on chromosome 19 by CRISPR/Cas9.c.The next day, visualize GFP-positive cells under a fluorescence microscope.Note: The number of GFP-positive cells will decrease over time, since only a subset of cells will have genomic integration. Transient GFP expression from non-integrated plasmid DNA decreases over time. Cells with stable genomic integration of the expression cassette are expected to retain GFP expression after 2 weeks.d.Culture the cells until confluency (4–7 days).e.Sort GFP-positive iPS cells using a FACSAria III cell sorter according to the gating strategy shown in Figures 5A–5C and 5F.Note: Sort one GFP-positive cell into each well of a 96-well plate and culture.Note: Before sorting, prepare the 96-well plate with StemFit, Y-27632, and iMatrix as described in the Note following step 9c(i).f.After confirming stable GFP expression, freeze the cells for future use.Note: It is important to confirm GFP expression two weeks after the lipofectamine transfection before future use.Pause point: The iPS cells can be cryopreserved at this stage. 10.Generate bPACF198Y-EGFP-expressing GPR161 KO iPS cells for optogeneticsa.Seed 6,000 GPR161 KO iPS cells in a 24-well plate.b.The next day, transfect the cells with the plasmids using Lipofectamine Stem Transfection Reagent.Note: For each well of a 24-well plate, dilute 1 μl of Lipofectamine Stem Transfection Reagent in 25 μl of Opti-MEM™ I Reduced Serum Medium. Separately, dilute 250 ng of pAAVS1-CAG-bPACF198Y-EGFP or pAAVS1-CAG-Arl13b-bPACF198Y-EGFP, together with 250 ng of pXAT2, in 25 μl of Opti-MEM™ I Reduced Serum Medium. Combine the two solutions, vortex for 2–3 s, and incubate at 20–25°C for 10 min. Add the resulting transfection mixture dropwise to the cells in the 24-well plate. The pAAVS1 vector and pXAT2 are used to target the AAVS1 locus on chromosome 19 by CRISPR/Cas9.c.The next day, visualize GFP-positive cells under a fluorescence microscope.Note: The number of GFP-positive cells will decrease over time, since only a subset of cells will have genomic integration. Transient GFP expression from non-integrated plasmid DNA decreases over time. Cells with stable genomic integration of the expression cassette are expected to retain GFP expression after 2 weeks.d.Culture the cells until confluency (4–7 days).e.Sort GFP-positive iPS cells using a FACSAria III cell sorter according to the gating strategy shown in Figures 5A–5C and 5F.Note: Sort one GFP-positive cell into each well of a 96-well plate and culture.Note: Before sorting, prepare the 96-well plate with StemFit, Y-27632, and iMatrix as described in the Note following step 9c(i).f.After confirming stable GFP expression, freeze the cells for future use.Note: It is important to confirm GFP expression two weeks after the lipofectamine transfection before future use.Pause point: The iPS cells can be cryopreserved at this stage. Generate bPACF198Y-EGFP-expressing GPR161 KO iPS cells for optogeneticsa.Seed 6,000 GPR161 KO iPS cells in a 24-well plate.b.The next day, transfect the cells with the plasmids using Lipofectamine Stem Transfection Reagent.Note: For each well of a 24-well plate, dilute 1 μl of Lipofectamine Stem Transfection Reagent in 25 μl of Opti-MEM™ I Reduced Serum Medium. Separately, dilute 250 ng of pAAVS1-CAG-bPACF198Y-EGFP or pAAVS1-CAG-Arl13b-bPACF198Y-EGFP, together with 250 ng of pXAT2, in 25 μl of Opti-MEM™ I Reduced Serum Medium. Combine the two solutions, vortex for 2–3 s, and incubate at 20–25°C for 10 min. Add the resulting transfection mixture dropwise to the cells in the 24-well plate. The pAAVS1 vector and pXAT2 are used to target the AAVS1 locus on chromosome 19 by CRISPR/Cas9.c.The next day, visualize GFP-positive cells under a fluorescence microscope.Note: The number of GFP-positive cells will decrease over time, since only a subset of cells will have genomic integration. Transient GFP expression from non-integrated plasmid DNA decreases over time. Cells with stable genomic integration of the expression cassette are expected to retain GFP expression after 2 weeks.d.Culture the cells until confluency (4–7 days).e.Sort GFP-positive iPS cells using a FACSAria III cell sorter according to the gating strategy shown in Figures 5A–5C and 5F.Note: Sort one GFP-positive cell into each well of a 96-well plate and culture.Note: Before sorting, prepare the 96-well plate with StemFit, Y-27632, and iMatrix as described in the Note following step 9c(i).f.After confirming stable GFP expression, freeze the cells for future use.Note: It is important to confirm GFP expression two weeks after the lipofectamine transfection before future use.Pause point: The iPS cells can be cryopreserved at this stage. a.Seed 6,000 GPR161 KO iPS cells in a 24-well plate. Seed 6,000 GPR161 KO iPS cells in a 24-well plate. b.The next day, transfect the cells with the plasmids using Lipofectamine Stem Transfection Reagent.Note: For each well of a 24-well plate, dilute 1 μl of Lipofectamine Stem Transfection Reagent in 25 μl of Opti-MEM™ I Reduced Serum Medium. Separately, dilute 250 ng of pAAVS1-CAG-bPACF198Y-EGFP or pAAVS1-CAG-Arl13b-bPACF198Y-EGFP, together with 250 ng of pXAT2, in 25 μl of Opti-MEM™ I Reduced Serum Medium. Combine the two solutions, vortex for 2–3 s, and incubate at 20–25°C for 10 min. Add the resulting transfection mixture dropwise to the cells in the 24-well plate. The pAAVS1 vector and pXAT2 are used to target the AAVS1 locus on chromosome 19 by CRISPR/Cas9. The next day, transfect the cells with the plasmids using Lipofectamine Stem Transfection Reagent.Note: For each well of a 24-well plate, dilute 1 μl of Lipofectamine Stem Transfection Reagent in 25 μl of Opti-MEM™ I Reduced Serum Medium. Separately, dilute 250 ng of pAAVS1-CAG-bPACF198Y-EGFP or pAAVS1-CAG-Arl13b-bPACF198Y-EGFP, together with 250 ng of pXAT2, in 25 μl of Opti-MEM™ I Reduced Serum Medium. Combine the two solutions, vortex for 2–3 s, and incubate at 20–25°C for 10 min. Add the resulting transfection mixture dropwise to the cells in the 24-well plate. The pAAVS1 vector and pXAT2 are used to target the AAVS1 locus on chromosome 19 by CRISPR/Cas9. Note: For each well of a 24-well plate, dilute 1 μl of Lipofectamine Stem Transfection Reagent in 25 μl of Opti-MEM™ I Reduced Serum Medium. Separately, dilute 250 ng of pAAVS1-CAG-bPACF198Y-EGFP or pAAVS1-CAG-Arl13b-bPACF198Y-EGFP, together with 250 ng of pXAT2, in 25 μl of Opti-MEM™ I Reduced Serum Medium. Combine the two solutions, vortex for 2–3 s, and incubate at 20–25°C for 10 min. Add the resulting transfection mixture dropwise to the cells in the 24-well plate. The pAAVS1 vector and pXAT2 are used to target the AAVS1 locus on chromosome 19 by CRISPR/Cas9. c.The next day, visualize GFP-positive cells under a fluorescence microscope.Note: The number of GFP-positive cells will decrease over time, since only a subset of cells will have genomic integration. Transient GFP expression from non-integrated plasmid DNA decreases over time. Cells with stable genomic integration of the expression cassette are expected to retain GFP expression after 2 weeks. The next day, visualize GFP-positive cells under a fluorescence microscope.Note: The number of GFP-positive cells will decrease over time, since only a subset of cells will have genomic integration. Transient GFP expression from non-integrated plasmid DNA decreases over time. Cells with stable genomic integration of the expression cassette are expected to retain GFP expression after 2 weeks. Note: The number of GFP-positive cells will decrease over time, since only a subset of cells will have genomic integration. Transient GFP expression from non-integrated plasmid DNA decreases over time. Cells with stable genomic integration of the expression cassette are expected to retain GFP expression after 2 weeks. d.Culture the cells until confluency (4–7 days). Culture the cells until confluency (4–7 days). e.Sort GFP-positive iPS cells using a FACSAria III cell sorter according to the gating strategy shown in Figures 5A–5C and 5F.Note: Sort one GFP-positive cell into each well of a 96-well plate and culture.Note: Before sorting, prepare the 96-well plate with StemFit, Y-27632, and iMatrix as described in the Note following step 9c(i). Sort GFP-positive iPS cells using a FACSAria III cell sorter according to the gating strategy shown in Figures 5A–5C and 5F.Note: Sort one GFP-positive cell into each well of a 96-well plate and culture.Note: Before sorting, prepare the 96-well plate with StemFit, Y-27632, and iMatrix as described in the Note following step 9c(i). Note: Sort one GFP-positive cell into each well of a 96-well plate and culture. Note: Before sorting, prepare the 96-well plate with StemFit, Y-27632, and iMatrix as described in the Note following step 9c(i). f.After confirming stable GFP expression, freeze the cells for future use.Note: It is important to confirm GFP expression two weeks after the lipofectamine transfection before future use.Pause point: The iPS cells can be cryopreserved at this stage. After confirming stable GFP expression, freeze the cells for future use.Note: It is important to confirm GFP expression two weeks after the lipofectamine transfection before future use.Pause point: The iPS cells can be cryopreserved at this stage. Note: It is important to confirm GFP expression two weeks after the lipofectamine transfection before future use. Pause point: The iPS cells can be cryopreserved at this stage. Key resources table REAGENT or RESOURCESOURCEIDENTIFIERAntibodiesARL13B (1:500 dilution)ProteintechCat. # 17711-1-AP, RRID:AB_2060867GFP (B-2) (1:500 dilution)Santa CruzCat. # sc-9996, RRID:AB_627695NKX2.1 (TTF-1; 8G7G3/1) (1:500 dilution)Diagnostic BioSystemsCat. # MOB285-01, RRID:AB_3730160PAX6 (1:500 dilution)BioLegendCat. # 901301, RRID:AB_2565003Goat anti-Rabbit Secondary Antibody, Alexa Fluor 594 (1:500 dilution)InvitrogenCat. # A-11037, RRID:AB_2534095Goat anti-Rabbit Secondary Antibody, Alexa Fluor 647 (1:500 dilution)InvitrogenCat. # A-21244, RRID:AB_2535812Goat anti-Mouse IgG1 Secondary Antibody, Alexa Fluor 555 (1:500 dilution)InvitrogenCat. # A-21127, RRID:AB_141596Goat anti-Mouse IgG2a Secondary Antibody, Alexa Fluor 488 (1:500 dilution)InvitrogenCat. # A-21131, RRID:AB_141618Chemicals, peptides, and recombinant proteinsTrypLE Express EnzymeGibcoCat. # 12604021Disodium EDTA dihydrateSigma-AldrichCat. # E5134StemFit® AK02NAjinomotoCat. # RCAK02NY-27632 DihydrochlorideChemsceneCat. # CS-0878iMatrix-511 silkTakara BioCat. # T311Stem Cell BankerTakara BioCat. # CB045Alt-R tracrRNA with ATTO 550Integrated DNA TechnologiesCat. # 1075927Alt-R S.p.HiFi Cas9 Nuclease V3Integrated DNA TechnologiesCat. # 1081060Electroporation Cuvette, 0.2 cmBio-RadCat. # 1652086DAPI (10 mg/ml)Sigma-AldrichCat. # D8417DMEM/F12InvitrogenCat. # 11330-032ATPSigma-AldrichCat. # 10519979001Magnesium chloride hexahydrateSigma-AldrichCat. # 19-0190-5Potassium phosphate monobasicSigma-AldrichCat. # P9791D-(+)-GlucoseNacalai TesqueCat. # 16806Sodium hydroxideSigma-AldrichCat. # 795429Sodium bicarbonateFUJIFILM Wako Pure ChemicalCat. # 191-0130596-well round bottom ultra-low attachment microplateCorningCat. # 7007Nunclon Sphera 96-Well, Nunclon Sphera-Treated, U-Shaped-Bottom MicroplateThermo Fisher ScientificCat. # 174925KnockOut Serum ReplacementThermo Fisher ScientificCat. # 10828010MEM Non-essential amino acids solution (MEM-NEAA; 100X)GibcoCat. # 11140050LDN-193189 (hydrochloride)Cayman ChemicalCat. # 19396SB-431542 (hydrate)Cayman ChemicalCat. # 13031XAV939Cayman ChemicalCat. # 135962-mercaptoethanolFUJIFILM Wako Pure ChemicalCat. # 133-14571200 mM L-GlutamineNacalai TesqueCat. # 16948-04Penicillin-Streptomycin Mixed SolutionNacalai TesqueCat. # 26253-84MACS Neuro MediumMiltenyi BiotecCat. # 130-093-570InsulinNacalai TesqueCat. # 12878-86N-2 MAX Media SupplementR&D SystemsCat. # AR009NeuroBrew-21 Supplement without Vitamin AMiltenyi BiotecCat. # 130-097-263NeuroBrew-21 SupplementMiltenyi BiotecCat. # 130-093-566L-Ascorbic acidSigma-AldrichCat. # A92902ParaformaldehydeFUJIFILM Wako Pure ChemicalCat. # 162-16065Tissue-Tek OCT CompoundSakura Finetek JapanCat. # 4583SucroseNacalai TesqueCat. # 09589-05Triton X-100Sigma-AldrichCat. # 30-5140-5Fluoromount-GSouthernBiotechCat. # 0100-01Normal Serum Block (Goat)BioLegendCat. # 927503Q5 High-Fidelity DNA PolymeraseNew England BiolabsCat. # M0491LDisposable Base Molds 15 mm X 15 mmTED PELLACat. # 27147-2Opti-MEM™ I Reduced Serum MediumGibcoCat. # 31985-062Fisherbrand™ Superfrost™ Plus Microscope SlidesFisher ScientificCat. # 12-550-15Micro slide glass FrontierMatsunami GlassCat. # FRC-01NEO CoverslipsMatsunami GlassCat. # C024601Critical commercial assaysLipofectamine Stem Transfection ReagentThermo Fisher ScientificCat. # STEM00001DNeasy Blood and Tissue Kits for DNA IsolationQiagenCat. # 69504Experimental models: Cell linesHuman 201B7 iPS cellsRiken201B7Human 201B7 iPS cells GPR161 KO2Shimada et al.,1N/ACyto-bPACF198Y-EGFP 201B7 GPR161 KO2 iPS cellsShimada et al.,1N/ACilia-bPACF198Y-EGFP 201B7 GPR161 KO2 iPS cellsShimada et al.,1N/AOligonucleotidesGPR161 crRNA-2 (Design ID: Hs.Cas9.GPR161.1.AE)Integrated DNA TechnologiesGATCTTCATGGGGTACACCAsgGpr161-FIntegrated DNA TechnologiesCCCTCCATCCCTTTTCTAGCsgGpr161-RIntegrated DNA TechnologiesCTCTGAGCATCCTCCTCCACGPR161ACseq primer-R1Integrated DNA TechnologiesCCATAGCACACCAGCATGACRecombinant DNApXAT2Oceguera-Yanez et al.8Addgene: #80494pAAVS1-CAG-bPACF198Y-EGFPShimada et al.,1N/ApAAVS1-CAG-Arl13b-bPACF198Y-EGFPShimada et al.,1N/ASoftware and algorithmsFiji (ImageJ) (Version 1.54f)RRID:SCR_002285https://imagej.net/software/fiji/downloadsOlympus Fluoview (Version 2.6)RRID:SCR_020339https://www.olympus-lifescience.com/en/laser-scanning/fv3000/BD FACSDiva (Version 9.4)RRID:SCR_001456https://www.bdbiosciences.com/en-usFlowJo (Version 10.8.1)RRID:SCR_008520https://www.flowjo.com/Arduino IDE 2.3.10RRID:SCR_024884https://www.arduino.cc/en/softwareArduino code for temporal control of LED illuminationThis paperhttps://zenodo.org/records/21673121Other35 mm dishCorningCat. # 4301656-well plateTPPCat. # 9240612-well plateTPPCat. # 9241224-well plateTPPCat. # 9212496-well plateTPPCat. # 92696Arduino Uno SMD R3ArduinoCat. # A000073Gravity: Easy Relay ModuleDFRobotCat. # DFR0643Male-to-male jumper wireDigikeyCat. # 1528-1967-NDDigital Sensor Cable for ArduinoDFRobotCat. # FIT0756Arduino caseHammond ManufacturingCat. # 1593HAMARTBU470-nm LED deviceOptocodeCat. # LEDB-SBOXHP660-nm LED stand lightOptocodeCat. # LED660-100STNDFluoview FV3000 Confocal microscopeOlympusN/ABD FACSAria IIIBD BiosciencesN/AOrbital shakerTAITECCat. # CS-LRNucleofector 2bLonzaCat. # AAB-1001CryostatLeicaCM1860UVCO2 incubatorPHCbiCat. # MCO-170AIC-PJUSB Type-A to Type-B data cableSanwa SupplyCat. # KU-R1AC adapter for LEDB-SBOXHPLi Tone ElectronicsLTE10UW-S4-BSA1; 24 V DC, 0.5 A; center-positiveAC adapter for the Arduino controllerLinkmanATS005T-W050U; 5 V DC, 1.0 A; center-positive REAGENT or RESOURCESOURCEIDENTIFIERAntibodiesARL13B (1:500 dilution)ProteintechCat. # 17711-1-AP, RRID:AB_2060867GFP (B-2) (1:500 dilution)Santa CruzCat. # sc-9996, RRID:AB_627695NKX2.1 (TTF-1; 8G7G3/1) (1:500 dilution)Diagnostic BioSystemsCat. # MOB285-01, RRID:AB_3730160PAX6 (1:500 dilution)BioLegendCat. # 901301, RRID:AB_2565003Goat anti-Rabbit Secondary Antibody, Alexa Fluor 594 (1:500 dilution)InvitrogenCat. # A-11037, RRID:AB_2534095Goat anti-Rabbit Secondary Antibody, Alexa Fluor 647 (1:500 dilution)InvitrogenCat. # A-21244, RRID:AB_2535812Goat anti-Mouse IgG1 Secondary Antibody, Alexa Fluor 555 (1:500 dilution)InvitrogenCat. # A-21127, RRID:AB_141596Goat anti-Mouse IgG2a Secondary Antibody, Alexa Fluor 488 (1:500 dilution)InvitrogenCat. # A-21131, RRID:AB_141618Chemicals, peptides, and recombinant proteinsTrypLE Express EnzymeGibcoCat. # 12604021Disodium EDTA dihydrateSigma-AldrichCat. # E5134StemFit® AK02NAjinomotoCat. # RCAK02NY-27632 DihydrochlorideChemsceneCat. # CS-0878iMatrix-511 silkTakara BioCat. # T311Stem Cell BankerTakara BioCat. # CB045Alt-R tracrRNA with ATTO 550Integrated DNA TechnologiesCat. # 1075927Alt-R S.p.HiFi Cas9 Nuclease V3Integrated DNA TechnologiesCat. # 1081060Electroporation Cuvette, 0.2 cmBio-RadCat. # 1652086DAPI (10 mg/ml)Sigma-AldrichCat. # D8417DMEM/F12InvitrogenCat. # 11330-032ATPSigma-AldrichCat. # 10519979001Magnesium chloride hexahydrateSigma-AldrichCat. # 19-0190-5Potassium phosphate monobasicSigma-AldrichCat. # P9791D-(+)-GlucoseNacalai TesqueCat. # 16806Sodium hydroxideSigma-AldrichCat. # 795429Sodium bicarbonateFUJIFILM Wako Pure ChemicalCat. # 191-0130596-well round bottom ultra-low attachment microplateCorningCat. # 7007Nunclon Sphera 96-Well, Nunclon Sphera-Treated, U-Shaped-Bottom MicroplateThermo Fisher ScientificCat. # 174925KnockOut Serum ReplacementThermo Fisher ScientificCat. # 10828010MEM Non-essential amino acids solution (MEM-NEAA; 100X)GibcoCat. # 11140050LDN-193189 (hydrochloride)Cayman ChemicalCat. # 19396SB-431542 (hydrate)Cayman ChemicalCat. # 13031XAV939Cayman ChemicalCat. # 135962-mercaptoethanolFUJIFILM Wako Pure ChemicalCat. # 133-14571200 mM L-GlutamineNacalai TesqueCat. # 16948-04Penicillin-Streptomycin Mixed SolutionNacalai TesqueCat. # 26253-84MACS Neuro MediumMiltenyi BiotecCat. # 130-093-570InsulinNacalai TesqueCat. # 12878-86N-2 MAX Media SupplementR&D SystemsCat. # AR009NeuroBrew-21 Supplement without Vitamin AMiltenyi BiotecCat. # 130-097-263NeuroBrew-21 SupplementMiltenyi BiotecCat. # 130-093-566L-Ascorbic acidSigma-AldrichCat. # A92902ParaformaldehydeFUJIFILM Wako Pure ChemicalCat. # 162-16065Tissue-Tek OCT CompoundSakura Finetek JapanCat. # 4583SucroseNacalai TesqueCat. # 09589-05Triton X-100Sigma-AldrichCat. # 30-5140-5Fluoromount-GSouthernBiotechCat. # 0100-01Normal Serum Block (Goat)BioLegendCat. # 927503Q5 High-Fidelity DNA PolymeraseNew England BiolabsCat. # M0491LDisposable Base Molds 15 mm X 15 mmTED PELLACat. # 27147-2Opti-MEM™ I Reduced Serum MediumGibcoCat. # 31985-062Fisherbrand™ Superfrost™ Plus Microscope SlidesFisher ScientificCat. # 12-550-15Micro slide glass FrontierMatsunami GlassCat. # FRC-01NEO CoverslipsMatsunami GlassCat. # C024601Critical commercial assaysLipofectamine Stem Transfection ReagentThermo Fisher ScientificCat. # STEM00001DNeasy Blood and Tissue Kits for DNA IsolationQiagenCat. # 69504Experimental models: Cell linesHuman 201B7 iPS cellsRiken201B7Human 201B7 iPS cells GPR161 KO2Shimada et al.,1N/ACyto-bPACF198Y-EGFP 201B7 GPR161 KO2 iPS cellsShimada et al.,1N/ACilia-bPACF198Y-EGFP 201B7 GPR161 KO2 iPS cellsShimada et al.,1N/AOligonucleotidesGPR161 crRNA-2 (Design ID: Hs.Cas9.GPR161.1.AE)Integrated DNA TechnologiesGATCTTCATGGGGTACACCAsgGpr161-FIntegrated DNA TechnologiesCCCTCCATCCCTTTTCTAGCsgGpr161-RIntegrated DNA TechnologiesCTCTGAGCATCCTCCTCCACGPR161ACseq primer-R1Integrated DNA TechnologiesCCATAGCACACCAGCATGACRecombinant DNApXAT2Oceguera-Yanez et al.8Addgene: #80494pAAVS1-CAG-bPACF198Y-EGFPShimada et al.,1N/ApAAVS1-CAG-Arl13b-bPACF198Y-EGFPShimada et al.,1N/ASoftware and algorithmsFiji (ImageJ) (Version 1.54f)RRID:SCR_002285https://imagej.net/software/fiji/downloadsOlympus Fluoview (Version 2.6)RRID:SCR_020339https://www.olympus-lifescience.com/en/laser-scanning/fv3000/BD FACSDiva (Version 9.4)RRID:SCR_001456https://www.bdbiosciences.com/en-usFlowJo (Version 10.8.1)RRID:SCR_008520https://www.flowjo.com/Arduino IDE 2.3.10RRID:SCR_024884https://www.arduino.cc/en/softwareArduino code for temporal control of LED illuminationThis paperhttps://zenodo.org/records/21673121Other35 mm dishCorningCat. # 4301656-well plateTPPCat. # 9240612-well plateTPPCat. # 9241224-well plateTPPCat. # 9212496-well plateTPPCat. # 92696Arduino Uno SMD R3ArduinoCat. # A000073Gravity: Easy Relay ModuleDFRobotCat. # DFR0643Male-to-male jumper wireDigikeyCat. # 1528-1967-NDDigital Sensor Cable for ArduinoDFRobotCat. # FIT0756Arduino caseHammond ManufacturingCat. # 1593HAMARTBU470-nm LED deviceOptocodeCat. # LEDB-SBOXHP660-nm LED stand lightOptocodeCat. # LED660-100STNDFluoview FV3000 Confocal microscopeOlympusN/ABD FACSAria IIIBD BiosciencesN/AOrbital shakerTAITECCat. # CS-LRNucleofector 2bLonzaCat. # AAB-1001CryostatLeicaCM1860UVCO2 incubatorPHCbiCat. # MCO-170AIC-PJUSB Type-A to Type-B data cableSanwa SupplyCat. # KU-R1AC adapter for LEDB-SBOXHPLi Tone ElectronicsLTE10UW-S4-BSA1; 24 V DC, 0.5 A; center-positiveAC adapter for the Arduino controllerLinkmanATS005T-W050U; 5 V DC, 1.0 A; center-positive Materials and equipment Induction medium (final volume: 10 ml)ReagentStock concentrationFinal concentrationAmountDMEM/F121×-7.67 mLKnockOut Serum Replacement100%20%2 mLMEM-NEAA100×1×100 μLL-glutamine100×1×100 μLPen/Strep100×1×100 μL2-mercaptoethanol1% (144 mM)0.0007% (100 μM)7 μLLDN-1931892 mM100 nM0.5 μLSB-43154210 mM10 μM10 μLXAV9392 mM2 μM10 μLStorage: Store at 4°C for up to 1 week. Cortical organoid medium 1 (final volume: 50 mL)ReagentStock concentrationFinal concentrationAmountDMEM/F12100%50%23.86 mLMACS Neuro medium100%50%23.86 mLN2 MAX supplement100×0.5×250 μLL-glutamine100×1×500 μLMEM-NEAA100×1×500 μLInsulin9.5–11.5 mg/ml∼2.5 μg/ml12.5 μL2-mercaptoethanol1% (144 mM)0.00035% (50 μM)17.5 μLPen/Strep100×1×500 μLNeuroBrew-21 Supplement without vitamin A50×0.5×500 μLStorage: Store at 4°C for up to 1 month. Cortical organoid medium 2 (final volume: 50 ml)ReagentStock concentrationFinal concentrationAmountDMEM/F12100%50%23.86 mLMACS Neuro medium100%50%23.86 mLN2 MAX supplement100×0.5×250 μLL-glutamine100×1×500 μLMEM-NEAA100×1×500 μLInsulin9.5–11.5 mg/ml∼2.5 μg/ml12.5 μL2-mercaptoethanol1% (144 mM)0.00035% (50 μM)17.5 μLPen/Strep100×1×500 μLAscorbic acid1 M200 μM10 μLNeuroBrew-21 Supplement50×0.5×500 μLStorage: Store at 4°C for up to 1 month. Solution AReagentStock concentrationAmountATP330 mM2 gMgCl2-6H2O590.3 mM1.2 gH2O—Bring to 10 mlStorage: Store at −20°C for up to 1 year. Solution BReagentStock concentrationAmountKH2PO488.2 mM6 gNaHCO314.3 mM0.6 gGlucose2.22 mM0.2 gNaOH—Adjust to pH 7.4H2O—Bring to 500 mlStorage: Store at −20°C for up to 1 year. Nucleofection solution (final volume: 500 μl)ReagentAmountSolution A10 μLSolution B490 μLStorage: Prepare fresh and use immediately. EDTA stock solution (final volume: 50 mL; final concentration: 0.5 M; pH 8)ReagentAmountDisodium EDTA-2H2O9.31 gNaOHAdjust to pH 8.0H2OBring to 50 mlStorage: Store at 4°C for up to 12 months. EDTA solution (final volume: 50 mL; final concentration: 0.5 mM)ReagentAmount0.5 M EDTA50 μLPBS (pH 7.4)49.95 mLStorage: Store at 4°C for up to 6 months. TrypLE/EDTA solution (final volume: 50 ml)ReagentAmountTrypLE25 mL0.5 mM EDTA solution25 mLStorage: Store at 4°C for up to 6 months. Induction medium (final volume: 10 ml)ReagentStock concentrationFinal concentrationAmountDMEM/F121×-7.67 mLKnockOut Serum Replacement100%20%2 mLMEM-NEAA100×1×100 μLL-glutamine100×1×100 μLPen/Strep100×1×100 μL2-mercaptoethanol1% (144 mM)0.0007% (100 μM)7 μLLDN-1931892 mM100 nM0.5 μLSB-43154210 mM10 μM10 μLXAV9392 mM2 μM10 μLStorage: Store at 4°C for up to 1 week. Induction medium (final volume: 10 ml) Storage: Store at 4°C for up to 1 week. Cortical organoid medium 1 (final volume: 50 mL)ReagentStock concentrationFinal concentrationAmountDMEM/F12100%50%23.86 mLMACS Neuro medium100%50%23.86 mLN2 MAX supplement100×0.5×250 μLL-glutamine100×1×500 μLMEM-NEAA100×1×500 μLInsulin9.5–11.5 mg/ml∼2.5 μg/ml12.5 μL2-mercaptoethanol1% (144 mM)0.00035% (50 μM)17.5 μLPen/Strep100×1×500 μLNeuroBrew-21 Supplement without vitamin A50×0.5×500 μLStorage: Store at 4°C for up to 1 month. Cortical organoid medium 1 (final volume: 50 mL) Storage: Store at 4°C for up to 1 month. Cortical organoid medium 2 (final volume: 50 ml)ReagentStock concentrationFinal concentrationAmountDMEM/F12100%50%23.86 mLMACS Neuro medium100%50%23.86 mLN2 MAX supplement100×0.5×250 μLL-glutamine100×1×500 μLMEM-NEAA100×1×500 μLInsulin9.5–11.5 mg/ml∼2.5 μg/ml12.5 μL2-mercaptoethanol1% (144 mM)0.00035% (50 μM)17.5 μLPen/Strep100×1×500 μLAscorbic acid1 M200 μM10 μLNeuroBrew-21 Supplement50×0.5×500 μLStorage: Store at 4°C for up to 1 month. Cortical organoid medium 2 (final volume: 50 ml) Storage: Store at 4°C for up to 1 month. Solution AReagentStock concentrationAmountATP330 mM2 gMgCl2-6H2O590.3 mM1.2 gH2O—Bring to 10 mlStorage: Store at −20°C for up to 1 year. Solution A Storage: Store at −20°C for up to 1 year. Solution BReagentStock concentrationAmountKH2PO488.2 mM6 gNaHCO314.3 mM0.6 gGlucose2.22 mM0.2 gNaOH—Adjust to pH 7.4H2O—Bring to 500 mlStorage: Store at −20°C for up to 1 year. Solution B Storage: Store at −20°C for up to 1 year. Nucleofection solution (final volume: 500 μl)ReagentAmountSolution A10 μLSolution B490 μLStorage: Prepare fresh and use immediately. Nucleofection solution (final volume: 500 μl) Storage: Prepare fresh and use immediately. EDTA stock solution (final volume: 50 mL; final concentration: 0.5 M; pH 8)ReagentAmountDisodium EDTA-2H2O9.31 gNaOHAdjust to pH 8.0H2OBring to 50 mlStorage: Store at 4°C for up to 12 months. EDTA stock solution (final volume: 50 mL; final concentration: 0.5 M; pH 8) Storage: Store at 4°C for up to 12 months. EDTA solution (final volume: 50 mL; final concentration: 0.5 mM)ReagentAmount0.5 M EDTA50 μLPBS (pH 7.4)49.95 mLStorage: Store at 4°C for up to 6 months. EDTA solution (final volume: 50 mL; final concentration: 0.5 mM) Storage: Store at 4°C for up to 6 months. TrypLE/EDTA solution (final volume: 50 ml)ReagentAmountTrypLE25 mL0.5 mM EDTA solution25 mLStorage: Store at 4°C for up to 6 months. TrypLE/EDTA solution (final volume: 50 ml) Storage: Store at 4°C for up to 6 months. Step-by-step method details Generate telencephalic organoids from iPS cells with the LED Timing: 2 weeks Timing: 2 weeks In this section, we describe how to generate telencephalic organoids from the engineered iPS cells using programmed LED exposure. Two CO2 incubators are required: one for the light-exposure plate and one for the dark-control plate. Other cultures may share the incubator as long as opening the incubator does not disrupt the programmed light-exposure or dark-control conditions.Note: The irradiance was approximately 6.0 mW/cm2 at approximately 5 mm from the illumination surface, measured approximately 1 min after the LED was turned on. This value is included as reference information provided by the manufacturer.Note: A 660-nm LED lamp should be installed in the tissue-culture hood and used during cell handling in a dark room.1.Culture iPS cells in one to two wells of a 12-well plate until they reach 60–70% confluency.Note: One to two wells generally provide enough cells for one 96-well plate, although the yield depends on the cell line and confluency.2.Dissociate the iPS cells and count the number of cells.3.Prepare the required number of cells at 3,000 cells per well.a.For 12 wells of a 96-well plate, prepare 39,000 cells in 1.3 ml of induction medium, corresponding to 36,000 cells for 12 wells plus an excess equivalent to one additional well.b.For a full 96-well plate, prepare at least 300,000 cells in 10 ml of induction medium.Note: Always prepare a small excess volume to compensate for pipetting loss.4.Centrifuge the cell suspension at 190 × g for 3 min and aspirate the supernatant.5.Resuspend the cells at 3,000 cells per 100 μl in induction medium containing 50 μM Y-27632, and dispense 100 μl into each well of a U-bottom ultra-low binding 96-well plate.Note: Place only the LED illumination unit inside the incubator, and keep the Arduino controller and power supply outside. Route the LED cable through an incubator access port, if available. If no access port is available, pass the cable through the gap between the incubator door and frame without pinching or sharply bending it. Close the door and confirm that the remaining gap is minimal. If necessary, cover any small residual gap around the cable with Parafilm.CRITICAL: After routing the LED cable, confirm that the incubator temperature and CO2 concentration remain stable.6.Establish the light-exposure and dark-control conditions.a.Place the 96-well plate on the LED and turn on the switch for the light-exposure condition.b.Place another 96-well plate into a separate CO2 incubator for the dark-control condition.CRITICAL: From step 6 onward, handle both the light-exposure and dark-control cultures under a 660-nm LED light.CRITICAL: Make sure the room is dark, and do not open the light-exposed or dark-control CO2 incubator when the room lights are on.7.Change half of the medium every 2–3 days until day 6.Note: Y-27632 is used only for the first two days; therefore, Y-27632 is not required at this stage.Note: Using a 200 μl tip, gently aspirate 50 μl of medium from the top surface. Healthy organoids sink to the bottom, so aspirating from the top helps prevent accidental removal of organoids.Note: Use a dark blue sheet or object on the clean bench to help visualize the organoids. Because the organoids are white or transparent, a dark blue background makes them easier to see.Note: If you do not see the aggregates at the bottom on day 1, it is possible that Y-27632 was not added on day 0.8.On day 6, aspirate all of the medium and then add 100 μl of cortical organoid medium 1.Note: Completely aspirating all the medium may be difficult at first. In that case, aspirate about 90% of the medium and add 100 μl of cortical organoid medium 1. Then aspirate about 90% of the medium again and add another 100 μl of cortical organoid medium 1. This stepwise dilution method makes the medium change easier.9.Change half of the medium every 2–3 days until day 14.Note: For organoid culture beyond day 14, transfer the organoids to a 6-well plate. Replace the medium with 1.5 ml of cortical organoid medium 2, and culture them on an orbital shaker, such as Taitec CS-LR or equivalent, at 70 rpm. Replace half of the medium every 1–4 days. Because the orbital shaker platform is larger than the LED unit, the LED unit can be placed on the shaker and the culture plate positioned on top of it. Make sure that the cable has sufficient slack and does not become tangled, caught, or disconnected during shaking. Note: The irradiance was approximately 6.0 mW/cm2 at approximately 5 mm from the illumination surface, measured approximately 1 min after the LED was turned on. This value is included as reference information provided by the manufacturer. Note: A 660-nm LED lamp should be installed in the tissue-culture hood and used during cell handling in a dark room. 1.Culture iPS cells in one to two wells of a 12-well plate until they reach 60–70% confluency. Culture iPS cells in one to two wells of a 12-well plate until they reach 60–70% confluency. Note: One to two wells generally provide enough cells for one 96-well plate, although the yield depends on the cell line and confluency. 2.Dissociate the iPS cells and count the number of cells. Dissociate the iPS cells and count the number of cells. 3.Prepare the required number of cells at 3,000 cells per well.a.For 12 wells of a 96-well plate, prepare 39,000 cells in 1.3 ml of induction medium, corresponding to 36,000 cells for 12 wells plus an excess equivalent to one additional well.b.For a full 96-well plate, prepare at least 300,000 cells in 10 ml of induction medium. Prepare the required number of cells at 3,000 cells per well.a.For 12 wells of a 96-well plate, prepare 39,000 cells in 1.3 ml of induction medium, corresponding to 36,000 cells for 12 wells plus an excess equivalent to one additional well.b.For a full 96-well plate, prepare at least 300,000 cells in 10 ml of induction medium. a.For 12 wells of a 96-well plate, prepare 39,000 cells in 1.3 ml of induction medium, corresponding to 36,000 cells for 12 wells plus an excess equivalent to one additional well. For 12 wells of a 96-well plate, prepare 39,000 cells in 1.3 ml of induction medium, corresponding to 36,000 cells for 12 wells plus an excess equivalent to one additional well. b.For a full 96-well plate, prepare at least 300,000 cells in 10 ml of induction medium. For a full 96-well plate, prepare at least 300,000 cells in 10 ml of induction medium. Note: Always prepare a small excess volume to compensate for pipetting loss. 4.Centrifuge the cell suspension at 190 × g for 3 min and aspirate the supernatant. Centrifuge the cell suspension at 190 × g for 3 min and aspirate the supernatant. 5.Resuspend the cells at 3,000 cells per 100 μl in induction medium containing 50 μM Y-27632, and dispense 100 μl into each well of a U-bottom ultra-low binding 96-well plate. Resuspend the cells at 3,000 cells per 100 μl in induction medium containing 50 μM Y-27632, and dispense 100 μl into each well of a U-bottom ultra-low binding 96-well plate. Note: Place only the LED illumination unit inside the incubator, and keep the Arduino controller and power supply outside. Route the LED cable through an incubator access port, if available. If no access port is available, pass the cable through the gap between the incubator door and frame without pinching or sharply bending it. Close the door and confirm that the remaining gap is minimal. If necessary, cover any small residual gap around the cable with Parafilm. CRITICAL: After routing the LED cable, confirm that the incubator temperature and CO2 concentration remain stable. 6.Establish the light-exposure and dark-control conditions.a.Place the 96-well plate on the LED and turn on the switch for the light-exposure condition.b.Place another 96-well plate into a separate CO2 incubator for the dark-control condition. Establish the light-exposure and dark-control conditions.a.Place the 96-well plate on the LED and turn on the switch for the light-exposure condition.b.Place another 96-well plate into a separate CO2 incubator for the dark-control condition. a.Place the 96-well plate on the LED and turn on the switch for the light-exposure condition. Place the 96-well plate on the LED and turn on the switch for the light-exposure condition. b.Place another 96-well plate into a separate CO2 incubator for the dark-control condition. Place another 96-well plate into a separate CO2 incubator for the dark-control condition. CRITICAL: From step 6 onward, handle both the light-exposure and dark-control cultures under a 660-nm LED light. CRITICAL: Make sure the room is dark, and do not open the light-exposed or dark-control CO2 incubator when the room lights are on. 7.Change half of the medium every 2–3 days until day 6. Change half of the medium every 2–3 days until day 6. Note: Y-27632 is used only for the first two days; therefore, Y-27632 is not required at this stage. Note: Using a 200 μl tip, gently aspirate 50 μl of medium from the top surface. Healthy organoids sink to the bottom, so aspirating from the top helps prevent accidental removal of organoids. Note: Use a dark blue sheet or object on the clean bench to help visualize the organoids. Because the organoids are white or transparent, a dark blue background makes them easier to see. Note: If you do not see the aggregates at the bottom on day 1, it is possible that Y-27632 was not added on day 0. 8.On day 6, aspirate all of the medium and then add 100 μl of cortical organoid medium 1. On day 6, aspirate all of the medium and then add 100 μl of cortical organoid medium 1. Note: Completely aspirating all the medium may be difficult at first. In that case, aspirate about 90% of the medium and add 100 μl of cortical organoid medium 1. Then aspirate about 90% of the medium again and add another 100 μl of cortical organoid medium 1. This stepwise dilution method makes the medium change easier. 9.Change half of the medium every 2–3 days until day 14. Change half of the medium every 2–3 days until day 14. Note: For organoid culture beyond day 14, transfer the organoids to a 6-well plate. Replace the medium with 1.5 ml of cortical organoid medium 2, and culture them on an orbital shaker, such as Taitec CS-LR or equivalent, at 70 rpm. Replace half of the medium every 1–4 days. Because the orbital shaker platform is larger than the LED unit, the LED unit can be placed on the shaker and the culture plate positioned on top of it. Make sure that the cable has sufficient slack and does not become tangled, caught, or disconnected during shaking. Fix and stain the organoids Timing: 1 week Timing: 1 week This section describes how to fix, cryoprotect, cryosection, stain, and image the telencephalic organoids.10.Transfer the organoids to a new 1.5 ml tube and fix them with 700 μl of 4% paraformaldehyde in PBS at 4°C for 3–4 h.Note: To collect organoids, cut the end of a pipette tip to widen the opening.11.Discard the paraformaldehyde and add 700 μl of 30% sucrose in PBS and incubate at 4°C for 12–16 h.12.Transfer the organoids to a disposable base mold and aspirate the remaining sucrose. Add OCT compound and freeze the OCT-embedded organoids at −80°C.Note: Position the organoids near one edge of the mold. This makes it easier to locate the organoid when sectioning.Pause point: Store the OCT-embedded organoids at −80°C until sectioning.13.Cut 16-μm frozen sections using a cryostat and transfer the sections onto adhesive slides to reduce detachment of OCT-embedded tissue during staining.Pause point: If not used immediately, store the sections at −20°C for up to 1 year.14.Block and stain the sections.a.Wash the sections in PBS to dissolve OCT compound, then block at 20–25°C for 1 h in blocking buffer containing 3% normal goat serum and 0.3% Triton X-100 in PBS.b.Incubate with the primary antibodies diluted in the blocking buffer containing 3% normal goat serum and 0.3% Triton X-100 in PBS at 4°C for 12–16 h.c.Wash with PBS and incubate with secondary antibodies and DAPI (1:500) diluted in the blocking buffer containing 3% normal goat serum and 0.3% Triton X-100 in PBS for 1 h at 20–25°C.d.Mount the sections with coverslips using Fluoromount-G.15.Acquire images using a microscope. 10.Transfer the organoids to a new 1.5 ml tube and fix them with 700 μl of 4% paraformaldehyde in PBS at 4°C for 3–4 h. Transfer the organoids to a new 1.5 ml tube and fix them with 700 μl of 4% paraformaldehyde in PBS at 4°C for 3–4 h. Note: To collect organoids, cut the end of a pipette tip to widen the opening. 11.Discard the paraformaldehyde and add 700 μl of 30% sucrose in PBS and incubate at 4°C for 12–16 h. Discard the paraformaldehyde and add 700 μl of 30% sucrose in PBS and incubate at 4°C for 12–16 h. 12.Transfer the organoids to a disposable base mold and aspirate the remaining sucrose. Add OCT compound and freeze the OCT-embedded organoids at −80°C. Transfer the organoids to a disposable base mold and aspirate the remaining sucrose. Add OCT compound and freeze the OCT-embedded organoids at −80°C. Note: Position the organoids near one edge of the mold. This makes it easier to locate the organoid when sectioning. Pause point: Store the OCT-embedded organoids at −80°C until sectioning. 13.Cut 16-μm frozen sections using a cryostat and transfer the sections onto adhesive slides to reduce detachment of OCT-embedded tissue during staining. Cut 16-μm frozen sections using a cryostat and transfer the sections onto adhesive slides to reduce detachment of OCT-embedded tissue during staining. Pause point: If not used immediately, store the sections at −20°C for up to 1 year. 14.Block and stain the sections.a.Wash the sections in PBS to dissolve OCT compound, then block at 20–25°C for 1 h in blocking buffer containing 3% normal goat serum and 0.3% Triton X-100 in PBS.b.Incubate with the primary antibodies diluted in the blocking buffer containing 3% normal goat serum and 0.3% Triton X-100 in PBS at 4°C for 12–16 h.c.Wash with PBS and incubate with secondary antibodies and DAPI (1:500) diluted in the blocking buffer containing 3% normal goat serum and 0.3% Triton X-100 in PBS for 1 h at 20–25°C.d.Mount the sections with coverslips using Fluoromount-G. Block and stain the sections.a.Wash the sections in PBS to dissolve OCT compound, then block at 20–25°C for 1 h in blocking buffer containing 3% normal goat serum and 0.3% Triton X-100 in PBS.b.Incubate with the primary antibodies diluted in the blocking buffer containing 3% normal goat serum and 0.3% Triton X-100 in PBS at 4°C for 12–16 h.c.Wash with PBS and incubate with secondary antibodies and DAPI (1:500) diluted in the blocking buffer containing 3% normal goat serum and 0.3% Triton X-100 in PBS for 1 h at 20–25°C.d.Mount the sections with coverslips using Fluoromount-G. a.Wash the sections in PBS to dissolve OCT compound, then block at 20–25°C for 1 h in blocking buffer containing 3% normal goat serum and 0.3% Triton X-100 in PBS. Wash the sections in PBS to dissolve OCT compound, then block at 20–25°C for 1 h in blocking buffer containing 3% normal goat serum and 0.3% Triton X-100 in PBS. b.Incubate with the primary antibodies diluted in the blocking buffer containing 3% normal goat serum and 0.3% Triton X-100 in PBS at 4°C for 12–16 h. Incubate with the primary antibodies diluted in the blocking buffer containing 3% normal goat serum and 0.3% Triton X-100 in PBS at 4°C for 12–16 h. c.Wash with PBS and incubate with secondary antibodies and DAPI (1:500) diluted in the blocking buffer containing 3% normal goat serum and 0.3% Triton X-100 in PBS for 1 h at 20–25°C. Wash with PBS and incubate with secondary antibodies and DAPI (1:500) diluted in the blocking buffer containing 3% normal goat serum and 0.3% Triton X-100 in PBS for 1 h at 20–25°C. d.Mount the sections with coverslips using Fluoromount-G. Mount the sections with coverslips using Fluoromount-G. 15.Acquire images using a microscope. Acquire images using a microscope. Expected outcomes The LED turns on and off according to the programmed settings. In this protocol, we used a 100 ms ON and 2 min OFF cycle. The duration of the cycle can be changed depending on the experimental design. Figure 3 shows the assembled devices, and Figures 4B and 4C show programmed LED OFF and ON states, respectively. Using GPR161 KO iPS cells expressing either cytoplasmic (cyto)-bPACF198Y-EGFP or cilia-bPACF198Y-EGFP, we generated telencephalic organoids (Figures 6A and 6B). Immunohistochemistry showed GFP localization in the cytoplasm of cytoplasmic-bPACF198Y-EGFP-GPR161 KO organoids or in the cilia of cilia-bPACF198Y-EGFP-GPR161 KO organoids (Figures 6A and 6B). Without light exposure, GPR161 KO organoids showed reduced expression of the dorsal NSC marker, paired box 6 (PAX6), and increased ectopic expression of the ventral NSC marker NK2 homeobox 1 (NKX2.1) in the ventricular zone of the organoids (Figures 6C and 6D). Since GPR161 deletion reduces cAMP levels, we increased cAMP by activating either cyto- or cilia-targeted bPACF198Y. After two weeks of light exposure, consistent with the quantitative findings reported by Shimada et al.,1 representative images showed decreased NKX2.1 staining and increased PAX6 staining under both cyto-bPACF198Y and cilia-bPACF198Y conditions. These data are consistent with successful optogenetic elevation of cAMP signaling.Figure 6Programmed light exposure regulates dorsal/ventral patterning of GPR161 KO organoids(A and B) GFP signals in the ventricular zone of cyto-bPACF198Y-EGFP- and cilia-bPACF198Y-EGFP-expressing GPR161 KO organoids. Cilia-bPACF198Y-EGFP was observed in ARL13B-positive primary cilia. White boxed regions are enlarged on the right, showing separate channels and merged images. White arrows indicate primary cilia.(C and D) Representative images of (C) PAX6-positive or (D) NKX2.1-positive NSCs in the ventricular zones of telencephalic organoids. Scale bars: (A and B) 20 μm and (C and D) 100 μm. Programmed light exposure regulates dorsal/ventral patterning of GPR161 KO organoids (A and B) GFP signals in the ventricular zone of cyto-bPACF198Y-EGFP- and cilia-bPACF198Y-EGFP-expressing GPR161 KO organoids. Cilia-bPACF198Y-EGFP was observed in ARL13B-positive primary cilia. White boxed regions are enlarged on the right, showing separate channels and merged images. White arrows indicate primary cilia. (C and D) Representative images of (C) PAX6-positive or (D) NKX2.1-positive NSCs in the ventricular zones of telencephalic organoids. Scale bars: (A and B) 20 μm and (C and D) 100 μm. Limitations One of the limitations of the programmed LED system is that it relies on the internal clock of the Arduino. Compared with highly accurate reference clocks, the Arduino clock has some variability. Therefore, over a 2-week period, there may be slight drift in the exact timing of light cycles relative to absolute time and, consequently, slight variation in the number of cycles delivered within a fixed interval. Nevertheless, the current device was sufficient to affect biological systems in the organoids, indicating that it may serve as a first step toward broader use of optogenetics in the life sciences. A limitation of this system is its scalability. Large-batch experiments may require multiple LED illumination units, and scaling long-term cultures to multiple plates may also require multiple orbital shakers. Troubleshooting Problem 1 The Arduino IDE shows an error and the LED program does not work. Related to step 6 in “Write the program.” Potential solution Make sure the code has no typos. Make sure that the code was uploaded successfully. Check the wire connections among all components. Check the version of the Arduino IDE. Problem 2 The LED does not light up. Related to steps 4–6 under “before you begin”. Potential solution Check the connections among the LED unit, Gravity: Easy Relay Module, 24-V adapter, Arduino, and jumper wires. High temperature and humidity may damage the LED illumination unit. Problem 3: The organoids do not form Related to steps 1–4 in “Generate telencephalic organoids from iPS cells with the LED.” Potential solution Confirm that the induction medium is fresh. Confirm that Y-27632 was included. Some iPS cell lines do not efficiently generate telencephalic organoids. Use 201B7 iPS cells or another iPS cell line that has been shown to generate telencephalic organoids. Problem 4: Organoids in the light-exposed condition look unhealthy after 2 weeks Related to steps 6–9 in “Generate telencephalic organoids from iPS cells with the LED.” Potential solution Prolonged LED exposure may increase the culture temperature or otherwise stress the organoids. Confirm that the incubator temperature remains stable during illumination, and reduce the illumination duration or frequency if necessary. To assess possible cell stress, researchers may use a cell stress or viability assay. Resource availability Lead contact Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Issei S. Shimada (ishimada@med.nagoya-cu.ac.jp). Technical contact Technical questions on executing this protocol should be directed to and will be answered by the technical contact, Issei S. Shimada (ishimada@med.nagoya-cu.ac.jp). Materials availability All unique reagents generated in this study are available from the lead contact with a completed materials transfer agreement. Data and code availability The code is shown in the code box in the “Write the program” section and in Figure 4. The code is available at Zenodo: https://zenodo.org/records/21673121. Acknowledgments This work was supported by the Outstanding Research Group Support Program of 10.13039/501100008883Nagoya City University grant no. (2401101), the Grant-in-Aid for Research in Nagoya City University (2621101) and 10.13039/501100000646Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (24K02425 and 26K23473 to I.S.S. and 26K09889 to Y.K.). We thank the Research Equipment Sharing Center/Core Laboratory at Nagoya City University for technical assistance (JPMXS0441500026). We appreciate Kohki Shimada at Shioji Junior High School for his technical assistance. Author contributions I.S.S. and Y.K. conceived the project, designed the experiments, analyzed most of the data, and wrote the manuscript. I.S.S. performed most of the experiments. Declaration of interests The authors declare no competing interests. Declaration of generative AI and AI-assisted technologies in the writing process During the preparation of this work, the authors used ChatGPT 5.6 and DeepL Write to check for grammatical errors. After using these tools, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.